<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="capmc" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC3712979/" /><meta name="ncbi_app" content="pmc" />
        <!-- Logger end -->
        
        <title>Vitamin C restores healthy aging in a mouse model for Werner syndrome</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712979/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="FASEB journal : official publication of the Federation of American Societies for Experimental Biology" /><meta name="citation_title" content="Vitamin C restores healthy aging in a mouse model for Werner syndrome" /><meta name="citation_authors" content="Laurent Massip, Chantal Garand, Eric R. Paquet, Victoria C. Cogger, Jennifer N. O’Reilly, Leslee Tworek, Avril Hatherell, Carla G. Taylor, Eric Thorin, Peter Zahradka, David G. Le Couteur, Michel Lebel" /><meta name="citation_date" content="January 2010" /><meta name="citation_issue" content="1" /><meta name="citation_volume" content="24" /><meta name="citation_firstpage" content="158" /><meta name="citation_doi" content="10.1096/fj.09-137133" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3712979/?report=abstract" /><meta name="citation_pmid" content="19741171" /><meta name="DC.Title" content="Vitamin C restores healthy aging in a mouse model for Werner syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="PMC Canada manuscript submission" /><meta name="DC.Contributor" content="Laurent Massip" /><meta name="DC.Contributor" content="Chantal Garand" /><meta name="DC.Contributor" content="Eric R. Paquet" /><meta name="DC.Contributor" content="Victoria C. Cogger" /><meta name="DC.Contributor" content="Jennifer N. O’Reilly" /><meta name="DC.Contributor" content="Leslee Tworek" /><meta name="DC.Contributor" content="Avril Hatherell" /><meta name="DC.Contributor" content="Carla G. Taylor" /><meta name="DC.Contributor" content="Eric Thorin" /><meta name="DC.Contributor" content="Peter Zahradka" /><meta name="DC.Contributor" content="David G. Le Couteur" /><meta name="DC.Contributor" content="Michel Lebel" /><meta name="DC.Date" content="2010 Jan" /><meta name="DC.Identifier" content="10.1096/fj.09-137133" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Vitamin C restores healthy aging in a mouse model for Werner syndrome" /><meta property="og:type" content="article" /><meta property="og:description" content="Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-like DNA helicase. Mice lacking the helicase domain of the WRN homologue exhibit many phenotypic features of WS, including a prooxidant status and a shorter mean life span ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712979/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'/pmc/utils/ctxp/'" /><script type="text/javascript" src="/corehtml/pmc/ctxp/jquery.citationexporter.js">//</script><link rel="stylesheet" href="/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-capmc.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3712979/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3712979/pdf/nihms3020.pdf" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A2623B4D3966100000000004B004A.m_8" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>
    <body class="article">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br />
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=capmc%20author%20manuscript[filter]" class="navlink">PMC Canada Author Manuscripts</a></li><li class="accid">PMC3712979</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-capmc.png" alt="Logo of capmc" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="300,50,370,75" alt="About us" title="About us" href="http://www.cihr-irsc.gc.ca/e/37792.html" ref="http://www.cihr-irsc.gc.ca/e/37792.html" /><area shape="rect" coords="371,50,500,75" alt="À propos de nous" title="À propos de nous" href="http://www.cihr-irsc.gc.ca/f/37792.html" ref="reftype=publisher&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><span id="pmcmata">FASEB J</span>. Author manuscript; available in PMC 2013 Jul 16.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=19741171" target="pmc_ext" ref="reftype=publisher&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal"><span class="cit">FASEB J. 2010 Jan; 24(1): 158–172. </span></a></div><span class="fm-vol-iss-date">Published online 2009 Sep 9. </span> <span class="doi">doi:  <a href="//dx.doi.org/10.1096%2Ffj.09-137133" target="pmc_ext" ref="reftype=other&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1096/fj.09-137133</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3712979</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">CAMSID: </span><span>CAMS3020</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19741171">19741171</a></div></div></div></div></div><h1 class="content-title">Vitamin C restores healthy aging in a mouse model for Werner syndrome</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Massip%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897578907968" co-class="co-affbox">Laurent Massip</a>,<sup>*</sup> <a href="/pubmed/?term=Garand%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897580782256" co-class="co-affbox">Chantal Garand</a>,<sup>*</sup> <a href="/pubmed/?term=Paquet%20ER%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897613045904" co-class="co-affbox">Eric R. Paquet</a>,<sup>*</sup> <a href="/pubmed/?term=Cogger%20VC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897579914304" co-class="co-affbox">Victoria C. Cogger</a>,<sup>&#x02020;</sup> <a href="/pubmed/?term=O%26%23x02019%3BReilly%20JN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897574352880" co-class="co-affbox">Jennifer N. O&#x02019;Reilly</a>,<sup>&#x02020;</sup> <a href="/pubmed/?term=Tworek%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897571705872" co-class="co-affbox">Leslee Tworek</a>,<sup>&#x02021;</sup> <a href="/pubmed/?term=Hatherell%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897553713552" co-class="co-affbox">Avril Hatherell</a>,<sup>&#x02021;</sup> <a href="/pubmed/?term=Taylor%20CG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897572322608" co-class="co-affbox">Carla G. Taylor</a>,<sup>&#x02021;</sup> <a href="/pubmed/?term=Thorin%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897572320576" co-class="co-affbox">Eric Thorin</a>,<sup>&#x000a7;</sup> <a href="/pubmed/?term=Zahradka%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897613650512" co-class="co-affbox">Peter Zahradka</a>,<sup>&#x02021;</sup> <a href="/pubmed/?term=Le%20Couteur%20DG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897580771504" co-class="co-affbox">David G. Le Couteur</a>,<sup>&#x02020;</sup> and  <a href="/pubmed/?term=Lebel%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171" class="affpopup" co-rid="_co_idm139897615062848" co-class="co-affbox">Michel Lebel</a><sup>*,</sup><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139897578907968"><h3 class="no_margin">Laurent Massip</h3><p>  <sup>*</sup>Centre de Recherche en Canc&#x000e9;rologie de l&#x02019;Universit&#x000e9; Laval, H&#x000f4;pital H&#x000f4;tel-Dieu de Qu&#x000e9;bec, Qu&#x000e9;bec, Qu&#x000e9;bec, Canada</p><div>Find articles by <a href="/pubmed/?term=Massip%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Laurent Massip</a></div></div><div id="_co_idm139897580782256"><h3 class="no_margin">Chantal Garand</h3><p>  <sup>*</sup>Centre de Recherche en Canc&#x000e9;rologie de l&#x02019;Universit&#x000e9; Laval, H&#x000f4;pital H&#x000f4;tel-Dieu de Qu&#x000e9;bec, Qu&#x000e9;bec, Qu&#x000e9;bec, Canada</p><div>Find articles by <a href="/pubmed/?term=Garand%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Chantal Garand</a></div></div><div id="_co_idm139897613045904"><h3 class="no_margin">Eric R. Paquet</h3><p>  <sup>*</sup>Centre de Recherche en Canc&#x000e9;rologie de l&#x02019;Universit&#x000e9; Laval, H&#x000f4;pital H&#x000f4;tel-Dieu de Qu&#x000e9;bec, Qu&#x000e9;bec, Qu&#x000e9;bec, Canada</p><div>Find articles by <a href="/pubmed/?term=Paquet%20ER%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Eric R. Paquet</a></div></div><div id="_co_idm139897579914304"><h3 class="no_margin">Victoria C. Cogger</h3><p>  <sup>&#x02020;</sup>Centre for Education and Research on Ageing and ANZAC Research Institute, University of Sydney and Concord RG Hospital, Sydney, Australia</p><div>Find articles by <a href="/pubmed/?term=Cogger%20VC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Victoria C. Cogger</a></div></div><div id="_co_idm139897574352880"><h3 class="no_margin">Jennifer N. O&#x02019;Reilly</h3><p>  <sup>&#x02020;</sup>Centre for Education and Research on Ageing and ANZAC Research Institute, University of Sydney and Concord RG Hospital, Sydney, Australia</p><div>Find articles by <a href="/pubmed/?term=O%26%23x02019%3BReilly%20JN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Jennifer N. O&#x02019;Reilly</a></div></div><div id="_co_idm139897571705872"><h3 class="no_margin">Leslee Tworek</h3><p>  <sup>&#x02021;</sup>Canadian Centre for Agri-food Research in Health and Medicine, University of Manitoba and St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada</p><div>Find articles by <a href="/pubmed/?term=Tworek%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Leslee Tworek</a></div></div><div id="_co_idm139897553713552"><h3 class="no_margin">Avril Hatherell</h3><p>  <sup>&#x02021;</sup>Canadian Centre for Agri-food Research in Health and Medicine, University of Manitoba and St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada</p><div>Find articles by <a href="/pubmed/?term=Hatherell%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Avril Hatherell</a></div></div><div id="_co_idm139897572322608"><h3 class="no_margin">Carla G. Taylor</h3><p>  <sup>&#x02021;</sup>Canadian Centre for Agri-food Research in Health and Medicine, University of Manitoba and St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada</p><div>Find articles by <a href="/pubmed/?term=Taylor%20CG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Carla G. Taylor</a></div></div><div id="_co_idm139897572320576"><h3 class="no_margin">Eric Thorin</h3><p>  <sup>&#x000a7;</sup>Universit&#x000e9; de Montr&#x000e9;al, Montreal Heart Institute, Montreal, Qu&#x000e9;bec, Canada</p><div>Find articles by <a href="/pubmed/?term=Thorin%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Eric Thorin</a></div></div><div id="_co_idm139897613650512"><h3 class="no_margin">Peter Zahradka</h3><p>  <sup>&#x02021;</sup>Canadian Centre for Agri-food Research in Health and Medicine, University of Manitoba and St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada</p><div>Find articles by <a href="/pubmed/?term=Zahradka%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Peter Zahradka</a></div></div><div id="_co_idm139897580771504"><h3 class="no_margin">David G. Le Couteur</h3><p>  <sup>&#x02020;</sup>Centre for Education and Research on Ageing and ANZAC Research Institute, University of Sydney and Concord RG Hospital, Sydney, Australia</p><div>Find articles by <a href="/pubmed/?term=Le%20Couteur%20DG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">David G. Le Couteur</a></div></div><div id="_co_idm139897615062848"><h3 class="no_margin">Michel Lebel</h3><p>  <sup>*</sup>Centre de Recherche en Canc&#x000e9;rologie de l&#x02019;Universit&#x000e9; Laval, H&#x000f4;pital H&#x000f4;tel-Dieu de Qu&#x000e9;bec, Qu&#x000e9;bec, Qu&#x000e9;bec, Canada</p><div>Find articles by <a href="/pubmed/?term=Lebel%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19741171">Michel Lebel</a></div></div></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139897576398128_ai" style="display:none"><div class="fm-affl" lang="en" id="A1">  <sup>*</sup>Centre de Recherche en Canc&#x000e9;rologie de l&#x02019;Universit&#x000e9; Laval, H&#x000f4;pital H&#x000f4;tel-Dieu de Qu&#x000e9;bec, Qu&#x000e9;bec, Qu&#x000e9;bec, Canada</div><div class="fm-affl" lang="en" id="A2">  <sup>&#x02020;</sup>Centre for Education and Research on Ageing and ANZAC Research Institute, University of Sydney and Concord RG Hospital, Sydney, Australia</div><div class="fm-affl" lang="en" id="A3">  <sup>&#x02021;</sup>Canadian Centre for Agri-food Research in Health and Medicine, University of Manitoba and St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada</div><div class="fm-affl" lang="en" id="A4">  <sup>&#x000a7;</sup>Universit&#x000e9; de Montr&#x000e9;al, Montreal Heart Institute, Montreal, Qu&#x000e9;bec, Canada</div><div id="FN1"><sup>1</sup>Correspondence: Centre de Recherche en Canc&#x000e9;rologie, H&#x000f4;pital H&#x000f4;Dieu de Qu&#x000e9;bec, 9 McMahon St., Qu&#x000e9;bec, Qu&#x000e9;bec G1R 2J6, Canada. <a href="mailto:dev@null" data-email="ac.lavalu.qdhrc@lebel.lehcim" class="oemail">ac.lavalu.qdhrc@lebel.lehcim</a></div></div><div class="togglers"><a href="#" class="pmctoggle" rid="idm139897576398128_ai">Author information <span>►</span></a> <a href="#" class="pmctoggle" rid="idm139897576398128_cpl">Copyright and License information <span>►</span></a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="idm139897576398128_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="small"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=19741171" target="pmc_ext" ref="reftype=publisher&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal">FASEB J</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3712979/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="idm139897573051024" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139897573051024title">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-like DNA helicase. Mice lacking the helicase domain of the WRN homologue exhibit many phenotypic features of WS, including a prooxidant status and a shorter mean life span compared to wild-type animals. Here, we show that Wrn mutant mice also develop premature liver sinusoidal endothelial defenestration along with inflammation and metabolic syndrome. Vitamin C supplementation rescued the shorter mean life span of Wrn mutant mice and reversed several age-related abnormalities in adipose tissues and liver endothelial defenestration, genomic integrity, and inflammatory status. At the molecular level, phosphorylation of age-related stress markers like Akt kinase-specific substrates and the transcription factor NF-&#x003ba;B, as well as protein kinase C&#x003b4; and Hif-1&#x003b1; transcription factor levels, which are increased in the liver of Wrn mutants, were normalized by vitamin C. Vitamin C also increased the transcriptional regulator of lipid metabolism PPAR&#x003b1;. Finally, microarray and gene set enrichment analyses on liver tissues revealed that vitamin C decreased genes normally up-regulated in human WS fibroblasts and cancers, and it increased genes involved in tissue injury response and adipocyte dedifferentiation in obese mice. Vitamin C did not have such effect on wild-type mice. These results indicate that vitamin C supplementation could be beneficial for patients with WS.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">ascorbate, metabolism, microarrays, liver, adipocyte, inflammation</span></div></div><div id="idm139897580409312" class="tsec sec headless whole_rhythm"><p id="P2" class="p p-first">Aging is defined as a progressive deterioration of physiological functions that impairs the ability of an organism to maintain its homeostasis and consequently increases susceptibility to disease and death. Much of the recent progress in the understanding of aging has been fueled by the study of human progeroid syndromes (<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018509">1</a>). One fascinating human aging disorder is Werner syndrome (WS). WS is a human autosomal recessive disorder characterized by genomic instability and the premature onset of a number of age-related diseases, including osteoporosis, ocular cataracts, graying and loss of hair, diabetes mellitus, arteriosclerosis, and atherosclerosis (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018504">2</a>&#x02013;<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018552">5</a>). It is, to our knowledge, the human disease model closest to normal aging. The defective enzyme responsible for WS is a helicase/exonuclease involved in DNA repair, replication, transcription, and telomere maintenance (<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018590">6</a>&#x02013;<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018562">10</a>). We previously generated a mouse model with a deletion in the helicase domain of the murine WRN homologue (<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018561">11</a>) that recapitulates most of the WS phenotypes, including an abnormal hyaluronic acid excretion, higher reactive oxygen species (ROS) levels, increased genomic instability, and cancer incidence resulting in a 10 &#x02013;15% decreased mean life span (<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018558">12</a>, <a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018595">13</a>). In addition, both humans with WS and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice show hallmarks of a metabolic syndrome, including premature visceral obesity, hypertriglyceridemia, insulin-resistant type 2 diabetes, and associated cardiovascular diseases (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018524">13</a>). This is in contrast to <em>Wrn</em>-null mice, which do not exhibit the same phenotype as <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018549">14</a>). However, <em>Wrn-</em>null mice fed with a high-carbohydrate diet develop hyperinsulinemia and insulin resistance (<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018598">15</a>). Notably, a cross between <em>Wrn</em>-null mice and mice defective in telomerase activity resulted (after several back-crosses) in the generation of progenies exhibiting metabolic abnormalities reminiscent of a severe premature aging (<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018566">16</a>). Metabolic syndrome afflicts up to one-half of Western population and is considered an age-related, proinflammatory lipidic disorder (<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018503">17</a>). Identifying compounds that ameliorate premature aging syndromes or metabolic abnormalities has thus become of major interest for both of these syndromes and for aging more generally. The <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mouse provides a unique opportunity to test such compounds. In this study, we assessed the effect of vitamin C on metabolic parameters and hepatic tissue status of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice.</p><p id="P3" class="p">The liver plays a pivotal role in nutrient, drug, hormone, and metabolic waste product processing, thereby maintaining body homeostasis. The liver undergoes substantial changes in structure and function in old age. There are age-related changes in liver mass, blood flow, and hepatocyte as well as sinusoidal cell morphology (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018567">18</a>). These changes are associated with significant impairment of many hepatic metabolic and detoxification activities, with implications for systemic aging and age-related disease. For example, the age-related impairment of the hepatic metabolism of lipoproteins predisposes to cardiovascular disease (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018525">19</a>). We therefore hypothesized that the metabolic syndrome developed by <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice is due to an abnormal regulation of the redox environment and a rise in reactive oxygen species (ROS) production leading to a premature liver dysfunction normally associated with age. Here, we show for the first time that, in addition to dyslipidemia, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice exhibit a severe premature liver sinusoidal endothelial defenestration, a phenotype normally associated with old age (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018583">18</a>). Notably, long-term vitamin C treatment restored healthy aging in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice by reversing the activity and levels of several stress and inflammatory markers, while vitamin C had no effect on wild-type (WT) mice. Since, unlike mice, humans can only rely on external sources of ascorbic acid (they are not able to synthesize it <em>de novo</em>), our results suggest that a continuous long-term treatment of WS with high doses of vitamin C is a promising therapeutic approach for this syndrome.</p></div><div id="S1" class="tsec sec"><h2 class="head no_bottom_margin" id="S1title">MATERIALS AND METHODS</h2><div id="S2" class="sec sec-first"><h3>Animal model</h3><p id="P4" class="p p-first-last">Mice lacking part of the helicase domain of the <em>Wrn</em> gene were generated by homologous recombination, as described previously (<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018557">11</a>). In the process, 121 amino acid residues of the Wrn protein were deleted (aa 710 to 831). This study was performed on WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> homozygous animals on the pure C57BL/6 genetic background. Care of mice was in accordance with the guidelines of the Centre de Recherche en Canc&#x000e9;rologie de l&#x02019;Universit&#x000e9; Laval. Mice were housed in cages (containing a top filter) on static racks in a conventional animal facility at 22 &#x000b1; 2&#x000b0;C with 40&#x02013;50% humidity and a 12:12-h light-dark cycle (light cycle: 6:00 AM to 6:00 PM). All mice were fed <em>ad libitum</em> with Teklad Global (Madison, WI, USA) 18% protein rodent diet (5% fat). Animals were checked every day for any external mass, infection, bleeding, gasping, and overall decrease or change in activity or behavior. Mice that became immobile or moribund were sacrificed for histological examination of their organs, as described previously (<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018568">12</a>). A cohort of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> homozygous animals was given 0.4% L-ascorbate (w/v) in drinking water (<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018513">20</a>) for the indicated time.</p></div><div id="S3" class="sec"><h3>Blood analysis</h3><p id="P5" class="p p-first-last">Blood was harvested by puncturing the leg saphenous vein of mice immobilized under contention. No anesthesia was employed. Serum triglyceride levels were measured by an enzymatic method using a reagent kit from Roche Diagnostics (Indianapolis, IN, USA) that allows correction for free glycerol. Blood glucose concentration was measured with a FreeStyle Mini glucose meter (TheraSense, Kent, UK). Serum insulin was measured with the ultrasensitive mouse insulin ELISA assay kit from Alpco Diagnostics (Windham, NH, USA). An index of fasting insulin resistance, consisting of the product of fasting glucose and insulin, was calculated accordingly to the homeostasis model assessment of insulin resistance (HOMA-IR) described previously (<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018530">21</a>). Ascorbic acid in blood or tissue extract was measured with the ferric reducing ascorbate assay kit from BioVision Research Products (Mountain View, CA, USA).</p></div><div id="S4" class="sec"><h3>Detection of ROS and oxidative DNA damage in tissues</h3><p id="P6" class="p p-first-last">ROS and oxidative DNA damage measurements were performed as described previously (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018563">13</a>). Briefly, liver tissues were excised, rinsed with PBS to remove blood, and homogenized with a Dremel tissue homogenizer (BioSpec Products, Bartlesville, OK) in 1 ml of RIPA buffer (50 mM Tris HCl, pH 7.5; 150 mM NaCl; 1% Nonidet P-40; 0.1% SDS; and 0.5% deoxycholate). The homogenate (200 &#x003bc;l) was incubated with 10 &#x003bc;g/ml of the dye 2&#x02032;-7&#x02032; DCF diacetate (Sigma-Aldrich Canada, Oakville, ON, Canada) for 1 h at 37&#x000b0;C. This dye is highly fluorescent on oxidation. The oxidized dye was measured as described previously (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018521">13</a>). Protein concentrations were measured using the Bradford assay. The remaining tissues were embedded in paraffin for histology. Oxidative DNA damage was measured as described previously (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018594">13</a>).</p></div><div id="S5" class="sec"><h3>Sequencing of mitochondrial DNA</h3><p id="P7" class="p p-first-last">Mitochondrial DNA liver tissues were extracted from 10 mice as described previously (<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018564">22</a>). The D-loop control region of mitochondrial DNA was amplified and cloned into the PCR2.1 vector (Invitrogen, Carlsbad, CA, USA) for sequencing. Eight to 10 clones of each genotype and tissue were sequenced. The primers used for the PCR were MTC1 GCCAACTAGCCTCCATCTCATACTT, nt 15196&#x02013;15220; and MTC2 GGGCGGGTTGTTGGTTTCAC, nt 15701&#x02013;15720.</p></div><div id="S6" class="sec"><h3>Measurements of reduced glutathione</h3><p id="P8" class="p p-first-last">Blood glutathione (GSH) levels were quantified with the ApoGSH Glutathione Detection Kit from BioVision Research Products. The assay utilizes monochlorobimane (MCB), a dye that appears to form adduct exclusively with GSH. The GSH-bound MCB dye fluoresces blue. Fluorescence was measured with a Fluoroskan Ascent fluorescence spectrophotometer (Thermo Electron, Milford, MA, USA). The excitation and emission wavelengths used were 355 and 460 nm, respectively. For hepatic GSH tissue levels, livers were excised, rinsed with PBS to remove blood, and homogenized with a Dremel tissue homogenizer (BioSpec Products) in 1 ml of RIPA buffer. GSH was measured from the homogenate. Protein concentrations were measured using the Bradford assay.</p></div><div id="S7" class="sec"><h3>Measurements of ATP</h3><p id="P9" class="p p-first-last">Liver ATP levels were quantified with the ApoSensor ADP/ATP ratio assay kit from BioVision Research Products. The assay uses the enzyme luciferase to catalyze the formation of light from ATP and luciferin. Luminescence was measured with a Luminoskan Ascent luminometer (Thermo Electron). Livers were excised, rinsed with PBS to remove blood, and homogenized with a Dremel tissue homogenizer (BioSpec Products) in 1 ml of RIPA buffer. ATP was measured from the homogenate. Protein concentrations were measured using the Bradford assay.</p></div><div id="S8" class="sec"><h3>Electron microscopy of the liver sinusoid</h3><p id="P10" class="p p-first-last">Livers were harvested from 5 <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> control mice and 5 <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice that had been treated with ascorbate, all aged 6&#x02013;9 months. Liver specimens were fixed for electron microscopy, as described previously (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018516">23</a>). The specimens were perfused with fixative by injecting an aliquot of fixative (2% glutaraldehyde/3% paraformaldehyde in 0.1 M sodium cacodylate buffer, 0.1 M sucrose, and 2 mM CaCl<sub>2</sub>) into the specimen with a 25-gauge needle until the tissue hardened. Tissue was postfixed for 2 h. Fixed liver tissue was treated with 1% (w/v) osmium, then dehydrated in an ethanol gradient to 100%, and incubated for 10 min in hexamethyl-disilazane. Samples were mounted and sputter-coated with gold. Samples for scanning microscopy were examined using a Jeol JSM 6380LV scanning electron microscope (Jeol Ltd., Akishima, Japan). Ten random sinusoids were photographed from each liver. Analysis of fenestral diameter and frequency was made using the ImageJ image analysis program (U.S. National Institutes of Health, Bethesda, MD, USA) and excluding gaps (&#x0003e;300 nm diameter). Porosity was determined as the percentage of the endothelial surface perforated by fenestrations and is a function of both diameter and frequency of fenestrations. The number of fenestrations counted was 768 in the <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> controls and 3337 in the ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice.</p></div><div id="S9" class="sec"><h3>Protein analysis</h3><p id="P11" class="p p-first-last">Protein extraction and Western blotting were performed as described previously (<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018560">24</a>). Antibodies against phospho-Akt substrates, phospho-NF-&#x003ba;B, NF-&#x003ba;B, phospho-p38, p38, phospho-SAP/JNK, SAP/JNK, PKC&#x003b4;, and phospho-PKC&#x003b4; were purchased from Cell Signaling Technology (Danvers, MA, USA). The anti-TNF-&#x003b1; antibody was purchased from R&#x00026;D Systems (Minneapolis, MN, USA). Antibodies against senescence marker protein 30 (SMP30), CTGF, and PPAR&#x003b1; were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The anti-Hif-1&#x003b1; polyclonal antibody was a kind gift from Dr. D. Richard (Centre de Recherche en Canc&#x000e9;rologie, Quebec, QC, Canada). Finally, all horseradish peroxidase-conjugated secondary antibodies were purchased from Amersham Biosciences (Piscataway, NJ, USA). Proteins on the Western blots were visualized using an ECL kit (Amersham Biosciences). All antibodies were used as indicated by the manufacturers.</p></div><div id="S10" class="sec"><h3>Microarray analysis</h3><p id="P12" class="p p-first-last">Total RNA from the liver of 9-mo-old WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated (since weaning) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice was extracted on a CsCl cushion. RNAs were processed at the functional genomic platform of the Institut de Recherche Clinique de Montreal (Montreal, QC, Canada) and were hybridized onto mouse Agilent 60-mer Oligo Microarrays (44,000 genes/microarray; Agilent Technologies, Santa Clara, CA, USA) in quadruplicates with dye swap. Arrays were scanned on an Axon GenePix 4000B (Axon Instruments, Foster City, CA, USA). Data were extracted from images using GenePix 6.0 (Axon) with local background estimation. Lists of differentially expressed genes were generated using limma in BioConductor (<a href="http://www.bioconductor.org" ref="reftype=extlink&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.bioconductor.org</a>). The data were background subtracted using normexp and also normalized using the loess method. Correction for multiple hypothesis testing was performed using Benjamini-Hochberg. We have deposited all the raw data (accession number <a id="__tag_664018603" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE14549" ref="/geo/query/acc.cgi?acc=GSE14549"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE14549","term_id":"14549"}}</span>GSE14549</a>) in the U.S. National Center for Biotechnology Information public database Gene Expression Omnibus (<a href="http://www.ncbi.nlm.nih.gov/geo/" ref="reftype=extlink&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.ncbi.nlm.nih.gov/geo/</a>). Gene set enrichment analysis (GSEA) was applied using default parameters on a fold-change-sorted list of genes on the C2 curated gene sets database (<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018523">25</a>). Such databases contain gene sets from known pathways, expert-created pathways, and also gene sets extracted from PubMed publications. Real-time RT-PCR was performed with the FastStart SYBR Green Master kit (Roche Diagnostics) according to the manufacturer&#x02019;s protocol.</p></div><div id="S11" class="sec"><h3>Lactonase (SMP30) activity</h3><p id="P13" class="p p-first-last">SMP30 activity was measured by the change in absorbance of the pH indicator <em>p</em>-nitrophenol caused by free acid formation from the D-glucono-&#x003b4;-lactone, as described previously (<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018520">26</a>). Briefly, the reaction buffer contained 10 mM D-glucono-&#x003b4;-lactone, 10 mM Pipes (pH 6.4), 0.25 mM <em>p</em>-nitrophenol, 75 &#x003bc;M ZnCl<sub>2</sub>, and 2 &#x003bc;l of liver extract in a total volume of 200 &#x003bc;l. Livers were removed from mice and homogenized with ice-cold homogenization buffer (10 mM Tris&#x000b7;HCl, pH 8.0/1 mM phenyl methanesulfonyl fluoride) for 30 s at high speed with a Polytron homogenizer (Kinematica AG, Lucerne, Switzerland). The homogenate was centrifuged at 10,000 <em>g</em> for 10 min. The protein concentration of the sample was determined by the standard Bradford assay. The substrate solution was freshly prepared immediately before the assay. The reaction was followed by monitoring a decrease in absorbance at 405 nm. The rate of spontaneous hydrolysis of the lactone was subtracted from the total rate.</p></div><div id="S12" class="sec"><h3>Thioredoxin reductase activity</h3><p id="P14" class="p p-first-last">The thioredoxin reductase activity was measured with a thioredoxin reductase assay kit (BioVision Research Products) following the instructions of the manufacturer. Briefly, in this assay thioredoxin reductase catalyzes the reduction of 5,5&#x02032;-dithio-<em>bis</em>-(2-nitrobenzoic) acid (DTNB) with NADPH to 5-thio-2-nitrobenzoic acid (TNB<sup>2&#x02212;</sup>), which generates a strong yellow color (&#x003bb;<sub>max</sub> = 405 nm). Since in crude biological samples, other enzymes, such as glutathione reductase and glutathione peroxidase, can also reduce DTNB, a thioredoxin reductase-specific inhibitor was used to determine thioredoxin reductase specific activity. Two assays were performed: the first measured the total DTNB reduction by the sample, and the second measured the DTNB reduction by the sample in the presence of the thioredoxin reductase-specific inhibitor. The difference between the two results is the DTNB reduction by thioredoxin reductase.</p></div><div id="S13" class="sec"><h3>Cytochrome-b5-reductase activity</h3><p id="P15" class="p p-first-last">The cytochrome-b5-reductase activity was measured as described previously (<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018538">27</a>, <a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018582">28</a>). Briefly, liver tissues were homogenized in ice-cold 0.25 M sucrose and 10 mM HEPES-NaOH, pH 7.8 (iso-osmotic buffer, 4 ml/g of liver) with a cocktail of protease inhibitors (Roche Diagnostics, Indianapolis, IN, USA). The homogenate was centrifuged at 1000 <em>g</em> for 20 min at 4&#x000b0;C. The supernatant was then centrifuged at 12,000 <em>g</em> for 20 min at 4&#x000b0;C. The latter supernatant contained membranes (endoplasmic reticulum, mitochondrial, and cellular). The protein concentration of the sample was determined by the standard Bradford assay. The enzymatic reaction was carried out in a 50 mM phosphate buffer, pH 7.5 (<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018589">27</a>, <a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018506">28</a>), in the presence of 0.3 mM KCN (to inhibit oxidases) and 2 &#x003bc;M rotenone (to inhibit mitochondrial NADH cytochrome C reductases). The reaction was started by the addition of 0.5 mM NADH. Reduction of cytochromes was followed by monitoring the increase in absorbance at 550 nm with time.</p></div><div id="S14" class="sec sec-last"><h3>Statistical analysis</h3><p id="P16" class="p p-first-last">Data are presented as means &#x000b1; SE. The unpaired Student&#x02019;s, Kolmogorov-Smirnov&#x02019;s test for normality and the log-rank tests were all performed using an &#x003b1; level of 0.05 and a 2-sided hypothesis. Mitochondrial mutation rates were analyzed by the Wilcoxon test using an alpha level of 0.05 and a one-sided hypothesis. Differences between cohorts were considered significant at values of <em>P</em> &#x0003c; 0.05 in all statistical analyses. All statistical analyses were performed with R 2.6.0 (<a href="http://www.r-project.org" ref="reftype=extlink&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.r-project.org</a>).</p></div></div><div id="S15" class="tsec sec"><h2 class="head no_bottom_margin" id="S15title">RESULTS</h2><div id="S16" class="sec sec-first"><h3><em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice exhibit decreased blood GSH levels and increased liver oxidative stress</h3><p id="P17" class="p p-first-last">Patients with WS exhibit an imbalance in plasma GSH levels (<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018533">29</a>), suggesting a prooxidant status in such individuals. We thus examined GSH plasma levels in 4-and 9-mo-old <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> and WT mice. As indicated in <a href="/pmc/articles/PMC3712979/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1<em>A</em></span></a>, WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice increased plasma GSH levels with age (2.5-fold increase from 4- to 9-mo-old animals). However, GSH levels were always significantly lower in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (~20% lower). GSH is an important endogenous antioxidant produced by the liver. Thus, we examined ROS and oxidative DNA damage in liver tissues of these animals. There was no significant increase in ROS and oxidative DNA damage at 4 mo of age between WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (data not shown). At 9 mo of age, however, significantly higher amounts of ROS (<a href="/pmc/articles/PMC3712979/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1<em>B</em></span></a>) and oxidative DNA damage (<a href="/pmc/articles/PMC3712979/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1<em>C</em></span></a>) were detected in the livers of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals. We also examined the mitochondrial DNA mutation rate in liver tissues. Sequencing of the mitochondrial D-loop region cloned from mouse tissues showed a significant 1.7-fold mutation rate increase in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> livers (Wilcoxon test; <em>P</em>=0.036) compared to WT animals (<a href="/pmc/articles/PMC3712979/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). The higher mutation rate in liver mitochondrial DNA from <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice could have an effect on energy production in such mice. Thus, we examined the ATP levels in liver tissues of each cohort. Overall ATP level was 40% lower in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice than WT animals (<a href="/pmc/articles/PMC3712979/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1<em>D</em></span></a>). We finally examined lipid peroxidation and did not detect a significant difference between WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (data not shown).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3712979/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139897576667408" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f1.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f1.jpg" src="/pmc/articles/PMC3712979/bin/nihms3020f1.jpg" /></div><div id="largeobj_idm139897576667408" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3712979/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3712979/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p2">Blood GSH levels and oxidative stress in WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>A</em>) Blood ascorbate level in 4- and 9-mo-old mice; <em>n</em> = 6 for each cohort and measurement. <em>B</em>) Liver ROS levels in 9-mo-old mice; <em>n</em> = 10 (5 females, 5 males) for each cohort and measurement. <em>C</em>) Oxidative DNA damage levels in liver of 9-mo-old mice; <em>n</em> = 10 (5 females, 5 males) for each cohort and measurement. <em>D</em>) ATP levels in liver tissues of 9-mo-old WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice; <em>n</em> = 6 for each cohort and measurement. Bars represent means &#x000b1; SE. *<em>P</em> &#x0003c; 0.05 <em>vs.</em> WT; unpaired Student&#x02019;s <em>t</em> test.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>TABLE 1</h3><!--caption a7--><div class="caption"><p id="__p11">Effect of ascorbate on mitochondrial DNA mutation rate in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139897557893488" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Genotype, liver mitochondria</th><th valign="bottom" align="right" rowspan="1" colspan="1">Mutation/sequenced base pairs<sup>a</sup></th><th valign="bottom" align="center" rowspan="1" colspan="1">%</th><th valign="bottom" align="center" rowspan="1" colspan="1"><em>P</em> value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">WT</td><td align="right" valign="top" rowspan="1" colspan="1">10/5230</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em></td><td align="right" valign="top" rowspan="1" colspan="1">17/5214</td><td align="center" valign="top" rowspan="1" colspan="1">0.33</td><td align="center" valign="top" rowspan="1" colspan="1">0.036<sup>b</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> + ascorbate</td><td align="right" valign="top" rowspan="1" colspan="1">8/4607</td><td align="center" valign="top" rowspan="1" colspan="1">0.17</td><td align="center" valign="top" rowspan="1" colspan="1">0.068<sup>c</sup></td></tr></tbody></table></div><div id="largeobj_idm139897557893488" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3712979/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>a</sup>From cloned PCR fragments of mitochondrial D-loop control region. Primers are MTC1 GCCAACTAGCCTCCATCTCATACTT, nt 15196&#x02013;15220, and MTC2 GGGCGGGTTGTTGGTTTCAC, nt 15701&#x02013;15720.</div><div id="TFN2"><sup>b</sup>Wilcoxon test; WT <em>vs. Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>.</div><div id="TFN3"><sup>c</sup>Wilcoxon test; <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup> vs. Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> + ascorbate.</div></div></div></div><div id="S17" class="sec"><h3><em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice exhibit a severe sinusoidal endothelium defenestration</h3><p id="P18" class="p p-first-last">Morphological changes in the liver with old age are increasingly recognized and include defenestration of the sinusoidal endothelium (<a href="/pmc/articles/PMC3712979/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2<em>A</em>, <em>B</em></span></a>) (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018584">18</a>). As this change also occurs with diabetes and may contribute to dyslipidemia (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018565">19</a>), we examined the morphology of hepatic sinusoids in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. A severe defenestration was observed in mutants from 7 mo onward (<a href="/pmc/articles/PMC3712979/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2<em>C</em>, <em>D</em></span></a>), which coincides with the appearance of significant hyperlipidemia and the onset of diabetes in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018554">13</a>). The overall porosity (determined as the percentage of the endothelial surface perforated by fenestrations) was very low in the <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (0.91&#x000b1; 0.69%) compared to age-matched WT mice (4.1&#x000b1; 0.3%) (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018527">23</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3712979/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139897571529952" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f2.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f2.jpg" src="/pmc/articles/PMC3712979/bin/nihms3020f2.jpg" /></div><div id="largeobj_idm139897571529952" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3712979/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3712979/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p3">Effect of ascorbate on liver sinusoidal fenestrations. Scanning electron microscopy showing lumenal surface of the liver sinusoidal endothelium with fenestrations (diameter ~50&#x02013;100 nm) clustered into sieve plates in WT and ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>A</em>) WT mouse at 7 mo of age. <em>B</em>) WT mouse at 24 mo of age. <em>C</em>) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mouse at 7 mo of age. <em>D</em>) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mouse at 9 mo of age. <em>E</em>) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mouse at 9 mo of age treated with ascorbate since weaning. <em>F</em>) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mouse at 9 mo of age treated with ascorbate since 7 mo of age. All views &#x000d7;25,000.</p></div></div></div></div><div id="S18" class="sec"><h3>Vitamin C restores sinusoidal endothelium fenestration and normal metabolism in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals</h3><p id="P19" class="p p-first">Most vertebrates synthesize ascorbic acid, or vitamin C, <em>de novo</em>, but humans and a few other species have lost this faculty, rendering this molecule a necessary nutrient or vitamin. Ascorbic acid is a major physiological antioxidant that replenishes GSH levels, prevents high-caloric-diet-induced dyslipidemia (<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018591">30</a>) and also influences the outcome of several age-related disorders, such as diabetes mellitus, obesity, and atherosclerosis (<a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018529">31</a>). It is known that ascorbate delays replicative senescence of WS fibroblasts <em>in vitro</em> (<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018542">32</a>). Therefore, we investigated the role of ascorbate in the disease progression of our mouse model. At weaning, the drinking water of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice was supplemented daily with 0.4% sodium L-ascorbate (w/v) as described before (<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018518">20</a>). The overall porosity of the sinusoidal endothelium was increased to normal levels in ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (<a href="/pmc/articles/PMC3712979/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2<em>E</em></span></a>) from less than 1% of the area perforated (as reported above) to 6.53 &#x000b1; 4.97% (<em>t</em> test; <em>P</em>&#x0003c;0.000001, <em>n</em>=5 mice for each cohort). In addition, the diameter of the fenestrations was also increased by ascorbate (from 93.8&#x000b1;44.7 to 98.57&#x000b1;42.51 nm, <em>P</em>&#x0003c;0.005).</p><p id="P20">Diabetes, hyperlipidemia, and enhanced visceral fat accretion were reported in patients with WS (<a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018555">33</a>) and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018528">13</a>). The unfolding of these phenotypes was monitored in ascorbate-treated and untreated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. Overall, visceral and subcutaneous fat pads of 9-mo-old <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice were at least twice the weight of WT animals (<a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>A</em>, <em>B</em></span></a>). Ascorbate significantly limited this change by reducing the mean weight of treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice to similar values as those observed in WT animals. The same effect was observed for blood triglyceride (<a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>C</em></span></a>) and fasting glucose (<a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>D</em></span></a>) levels. Although fasting insulin levels were not significantly different between treated and untreated mutant mice (<a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>E</em></span></a>), a clear normalization of the insulin resistance was noted in treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice, as revealed by the HOMA-IR index (<a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>F</em></span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139897571528480" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3712979_nihms3020f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3712979/bin/nihms3020f3.jpg" /></a></div><div id="largeobj_idm139897571528480" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3712979/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3712979/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p4">Ascorbate treatment improves metabolism of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. Ascorbate was added to drinking water (0.4% w/v) of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice at weaning (30 wk treatment) or at the age of 7 mo (8-wk treatment). <em>A</em>) Visceral fat weight. <em>B</em>) Subcutaneous fat weight. <em>C</em>) Fasting blood triglyceride levels. <em>D</em>) Fasting blood glucose levels. <em>E</em>) Fasting insulin levels. <em>F</em>) HOMA-IR index for fasting WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. Bars represent means &#x000b1; SE. *<em>P</em> &#x0003c; 0.05 <em>vs. Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>; unpaired <em>t</em> test. Nine-month-old males (<em>n</em>=5) and females (<em>n</em>=5) of each cohort were used for all measurements. Data from males and females were pooled for glucose, insulin, and HOMA-IR histograms.</p></div></div></div><p id="P21">We next examined ROS and DNA damage levels in the liver of ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. We measured ROS and oxidative DNA damage in 5 males and 5 females of each cohort at 9 mo of age. As indicated before, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> males and females exhibited higher amounts of ROS (<a href="/pmc/articles/PMC3712979/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4<em>A</em></span></a>) and oxidative DNA damage (<a href="/pmc/articles/PMC3712979/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4<em>B</em></span></a>) in their liver compared to WT animals. Ascorbate treatment of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice reduced these amounts to equal or even inferior values than those observed in the WT cohort. We also examined the mitochondrial DNA mutation rate in liver tissues. The mutation rate tended to be reduced near to the basal WT levels by ascorbate treatment (<a href="/pmc/articles/PMC3712979/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). Nonetheless, ascorbate significantly rescued the ATP levels in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> liver tissues (<a href="/pmc/articles/PMC3712979/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4<em>C</em></span></a>). Since ATP level has an effect on AMPK&#x003b1; activity (<a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018597">34</a>), we also examined the level of phosphorylation of this kinase in livers of each cohort. As expected, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice showed an increase in AMPK&#x003b1; phosphorylation (<a href="/pmc/articles/PMC3712979/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4<em>D</em></span></a>). However, ascorbate treatment did not significantly decrease AMPK&#x003b1; phosphorylation in the liver of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. These results indicate that ascorbate treatment of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice since weaning rescued the abnormal metabolic phenotypes associated with this mouse model and normalized the endothelial morphology in liver tissues.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC3712979/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139897573478032" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3712979_nihms3020f4.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3712979/bin/nihms3020f4.jpg" /></a></div><div id="largeobj_idm139897573478032" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3712979/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC3712979/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p5">Ascorbate treatment improves ROS, oxidative DNA damage, and ATP balance in the liver of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>A</em>) Liver ROS levels in 9-mo-old males and females. <em>B</em>) Oxidative DNA damage in the liver of 9-mo-old animals. Ascorbate was added to drinking water (0.4% w/v) of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice containing cages at weaning (30-wk treatment) or at the age of 7 mo (8-wk treatment). <em>C</em>) ATP levels in liver tissues of 9-mo-old WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated (since weaning) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. Bars represent means &#x000b1; SE; <em>n</em> = 5 for each cohort (including males and females when indicated) and measurement. *<em>P</em> &#x0003c; 0.05 <em>vs. Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>; unpaired <em>t</em> test. <em>D</em>) Western blot showing expression of AMPK&#x003b1; and phosphorylated AMPK&#x003b1; in liver tissues of 9-mo-old WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated (since weaning) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>. &#x003b2;-Tubulin is used as loading control.</p></div></div></div><p id="P22" class="p p-last">Finally, we measured the daily water and food intake in WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals. The daily water and food intakes (5.2&#x000b1;1.4 ml/d and 3.5&#x000b1;0.6 g/d, respectively) were not significantly different between our three cohorts (data not shown).</p></div><div id="S19" class="sec"><h3>Short-term vitamin C treatment restores sinusoidal endothelium fenestration and overall fat tissue weight in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice</h3><p id="P23" class="p p-first-last">To determine whether a shorter treatment time has similar effects on <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice, we supplemented 7-mo-old <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice with ascorbate for 8 wk and repeated our measurements. Seven-month-old <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals already displayed metabolic abnormalities and a severe liver sinusoidal endothelial defenestration (<a href="/pmc/articles/PMC3712979/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2<em>E</em></span></a>). A normal sinusoidal refenestration was obtained in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice on this short-term ascorbate treatment (<a href="/pmc/articles/PMC3712979/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2<em>F</em></span></a>). Concomitant with these observations, an overall reduction of fat tissue weight to WT basal levels was observed with <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> males (<a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>A</em>, <em>B</em></span></a>). Visceral fat tissues from <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> females were more refractory to the short-term ascorbate treatment (<a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>A</em></span></a>), but subcutaneous fat tissue weight was significantly reduced (<a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>B</em></span></a>). Hypertriglyceridemia was not significantly reduced in short-term ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> males and females (<a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>C</em></span></a>). Although hyperinsulinemia was not significantly reduced in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice, a trend to normalization was observed in HOMA-IR index of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals after 8 wk of vitamin C treatment (<a href="/pmc/articles/PMC3712979/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>D</em>&#x02013;<em>F</em></span></a>). Interestingly, this short-term ascorbate treatment did not relieve ROS or oxidative DNA damage in liver tissues of treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (<a href="/pmc/articles/PMC3712979/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4<em>A</em>, <em>B</em></span></a>).</p></div><div id="S20" class="sec"><h3>GSEA of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice treated with ascorbate</h3><p id="P24" class="p p-first">To gain insight into the rescuing effect of vitamin C in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice, the global liver expression profile of WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>-treated and untreated mice at 9 mo of age was analyzed with the Agilent microarray technology. Lists of genes exhibiting a 1.5-fold change difference with a Benjamini-Hochberg false discovery rate (FDR) &#x0003c; 0.1 are shown in <a href="#SD5" rid="SD5" class=" supplementary-material">Supplemental Table 1</a> for <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice <em>vs.</em> WT animals and in <a href="#SD6" rid="SD6" class=" supplementary-material">Supplemental Table 2</a> for ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice <em>vs.</em> untreated WT animals. Real time RT-PCR confirmed the microarray data by analyzing the expression of 6 randomly picked genes listed from our WT <em>vs.</em> ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice data (see results in <a href="#SD6" rid="SD6" class=" supplementary-material">Supplemental Table 3</a>). A list of the primers for the genes analyzed is shown in <a href="#SD6" rid="SD6" class=" supplementary-material">Supplemental Table 4</a>.</p><p id="P25">Three hundred eighty-four genes exhibited a 1.5-fold alteration in expression in the liver of 9-mo-old <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals (194 down-regulated and 190 up-regulated, respectively) (<a href="#SD5" rid="SD5" class=" supplementary-material">Supplemental Table 1</a>). Two hundred ninety-six genes showed a 1.5-fold change in expression in ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals (139 down-regulated and 157 up-regulated, respectively) (<a href="#SD6" rid="SD6" class=" supplementary-material">Supplemental Table 2</a>). Sixty-eight genes were altered in both untreated and ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (<a href="/pmc/articles/PMC3712979/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5<em>A</em></span></a> and <a href="#SD7" rid="SD7" class=" supplementary-material">Supplemental Table 5</a>). However, 8 of these genes showed opposite expression change in ascorbate-treated and untreated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. Such genes included the immunoglobulin heavy chain (J558 family), a C-type lectin domain family 2 encoding gene, the ethanolamine kinase 2, the squalene epoxidase, the sulfotransferase family 2A encoding gene, the PHD finger protein 3, the major urinary protein 3, and one expression sequence tag (see <a href="#SD7" rid="SD7" class=" supplementary-material">Supplemental Table 5</a> for more details).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC3712979/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139897575119888" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3712979_nihms3020f5.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3712979/bin/nihms3020f5.jpg" /></a></div><div id="largeobj_idm139897575119888" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3712979/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC3712979/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p6">Distinct biological pathways associated with <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> and ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>A</em>) Venn diagram showing the number of genes overlapping between <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> and ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>B</em>) All significant gene set enrichments from liver tissues of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> and ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT liver control were grouped into biological and functional categories. Categories with family-wise error rate (FWER) &#x0003c; 0.05 are presented in the histogram.</p></div></div></div><p id="P26" class="p p-last">To obtain an unbiased analysis of gene sets or biological pathways up- or down-regulated in untreated and ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice, we analyzed the complete list of genes using the GSEA tool. GSEA is a way to assess whether a predefined list of genes in a specific pathway is significantly up- or down-regulated (<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018545">25</a>). The analysis generated a list of eight significant gene sets with a family-wise error rate (FWER) <em>P</em> value &#x0003c;0.05 for <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals and 11 significant gene sets for ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <a href="#SD6" rid="SD6" class=" supplementary-material">Supplemental Table 6</a> shows the gene enrichment sets down- or up-regulated in treated and untreated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals. The complete GSEA reports are provided online (<a href="http://www.crhdq.ulaval.ca/LiverWrn-Vitc" ref="reftype=extlink&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.crhdq.ulaval.ca/LiverWrn-Vitc</a>). As summarized in <a href="/pmc/articles/PMC3712979/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5<em>B</em></span></a>, sets from <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice included genes shown to be altered in <em>Acox1</em>-knockout and Myc/E2F1 transgenic mice developing hepatomas (<a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018526">35</a>). Liver tissue from <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice also exhibited alteration in genes involved in caloric restriction (<a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018579">36</a>), glutathione, and xenobiotic metabolism by cytochrome P450 pathways. These results suggest that <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice respond to the observed oxidative stress by altering the necessary pathways to survive. <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice also responded by up-regulating an inflammatory response in the liver (<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018507">37</a>). Ascorbate treatment, in return, significantly inhibited genes in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice known to be up-regulated in human WS fibroblasts (<a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018596">38</a>) (<a href="/pmc/articles/PMC3712979/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5<em>B</em></span></a>). Ascorbate also down-regulated pathways normally up-regulated in cancer, such as Myc or Myb transcriptional activities (<a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018588">35</a>, <a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018514">39</a>). Interestingly, ascorbate up-regulated genes in the pathway leading to the dedifferentiation of adipocytes in obese mice (<a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018532">40</a>). It also up-regulated genes normally decreased during B-lymphomagenesis (<a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018511">41</a>). Vitamin C augmented significantly several pathways involved in the response to tissue injury, including clearance of sick cells from infection or graft rejection (<a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018559">42</a>&#x02013;<a href="#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018508">45</a>). This is consistent with the increase in genes associated with the immune response category seen in <a href="#SD6" rid="SD6" class=" supplementary-material">Supplemental Table 2</a>. (Fisher exact test; <em>P</em>=0.02). Concomitant with such tissue injury response, ascorbate increased pathways involved in stem cell maturation and maintenance (<a href="#R46" rid="R46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018578">46</a>, <a href="#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018548">47</a>).</p></div><div id="S21" class="sec"><h3>Vitamin C normalizes GSH metabolism in the liver of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice</h3><p id="P27" class="p p-first">The increase in the expression of genes involved in xenobiotic and glutathione metabolism prompted us to examine GSH and ascorbate levels in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. Plasma ascorbate levels were not different in 4-mo-old <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice, which contrasts with the 3-fold increase observed in 9-mo-old <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals (<a href="/pmc/articles/PMC3712979/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6<em>A</em></span></a>). Despite this increase in blood ascorbate, GSH blood levels, which usually correlate with ascorbate amounts, remained significantly lower in mutant mice (<a href="/pmc/articles/PMC3712979/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1<em>A</em></span></a>). We next examined ascorbate levels in the liver of our 9-mo-old cohorts. As showed in <a href="/pmc/articles/PMC3712979/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6<em>B</em></span></a>, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice have higher ascorbate concentrations in the liver compared to WT animals. Finally, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice showed higher kidney ascorbate levels and lower urinary ascorbate concentration than WT animals at 9 mo of age (<a href="/pmc/articles/PMC3712979/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6<em>C, D</em></span></a>). Our results corroborate the findings in patients with WS (<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018585">29</a>) and suggest that <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice react to their metabolic anomalies by increasing their overall body ascorbate levels. We then quantified GSH levels in the liver of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. Unlike the blood GSH concentration, GSH levels were higher in the liver of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals (<a href="/pmc/articles/PMC3712979/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6<em>E</em></span></a>) in support of the liver GSEA data (<a href="/pmc/articles/PMC3712979/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5<em>B</em></span></a>). Interestingly, ascorbate treatment normalized both liver GSH and blood GSH levels in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (<a href="/pmc/articles/PMC3712979/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6<em>E</em>, <em>F</em></span></a>). The GSEA data of livers of ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice did not show significant change in the glutathione metabolic pathway (<a href="/pmc/articles/PMC3712979/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5<em>B</em></span></a> and <a href="#SD6" rid="SD6" class=" supplementary-material">Supplemental Table 6</a>) and correlated with normal GSH levels in treated mice. As expected, ascorbate levels were significantly increased in the blood of young <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice treated with vitamin C (<a href="/pmc/articles/PMC3712979/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6<em>G</em></span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC3712979/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139897572690000" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f6.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f6.jpg" src="/pmc/articles/PMC3712979/bin/nihms3020f6.jpg" /></div><div id="largeobj_idm139897572690000" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3712979/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC3712979/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6</a></div><!--caption a7--><div class="caption"><p id="__p7">Ascorbate and GSH levels in WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>A</em>) Blood ascorbate levels in 4 and 9-mo-old mice. <em>B</em>) Liver ascorbate levels in 9-mo-old mice. <em>C</em>) Kidney ascorbate levels in 9-mo-old mice. <em>D</em>) Urine ascorbate levels from 9-mo-old mice. <em>E</em>) Liver GSH level in 9-mo-old WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated (since weaning) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>F</em>) Blood GSH levels in 4-mo-old WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated (since weaning) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>G</em>) Blood ascorbate levels in 4-mo-old WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated (since weaning) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. All <em>P</em> values are from unpaired <em>t</em> tests; <em>n</em> = 5 for each cohort and measurement. Bars represent means &#x000b1; SE.</p></div></div></div><p id="P28">SMP30 (also known as <em>RGN</em>) is the penultimate enzyme in ascorbate biosynthesis and is known to decrease in liver with age (<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018581">26</a>). Examination of SMP30 protein level by Western blot analysis in 9-mo-old animals, however, failed to reveal any difference between <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> and WT animals (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Fig. 1<em>A</em></a>). The enzymatic activity of SMP30 was also the same in liver tissues of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> and WT animals (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Fig. 1<em>B</em></a>).</p><p id="P29">The last enzyme in ascorbate biosynthesis is the L-gulonolactone oxidase (Gulo). Real-time RT-PCR was performed for Gulo expression in liver samples, as no commercial antibody is available against mouse Gulo gene product. No difference in Gulo mRNA expression level was detected between WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals (<a href="#SD6" rid="SD6" class=" supplementary-material">Supplemental Table 3</a>), confirming the microarray data.</p><p id="P30">There are two other enzymes important for the intracellular metabolism of ascorbate, namely thioredoxin reductase and cytochrome-b5-reductase (<a href="#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018512">48</a>, <a href="#R49" rid="R49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018537">49</a>). There are several isoforms of thioredoxin reductase and cytochrome-b5-reductase in mice, but there is no commercial antibody to detect all of the different isoforms of these enzymes. On the basis of microarray data, however, there is no significant change in mRNA expression levels for all of these enzymes in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> compared to WT animals (<a href="#SD2" rid="SD2" class=" supplementary-material">Supplemental Fig. 2<em>A</em></a>). We next examined the overall enzymatic activities of thioredoxin reductase and cytochrome-b5-reductase in the liver of these mice. No difference was detected in the enzymatic activities of thioredoxin reductase and cytochrome-b5-reductase in the liver tissues of WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals (<a href="#SD2" rid="SD2" class=" supplementary-material">Supplemental Fig. 2<em>B</em>, <em>C</em></a>).</p><p id="P31" class="p p-last">Finally, the amount of liver and kidney ascorbate transporter SVCT1 (<a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018571">50</a>) was not changed in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals (data not shown). GSEA did not revealed changes in genes sets involved in ascorbate metabolism or transport in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice confirming the above results. Thus, the reason for the ascorbate increase in 9-mo-old <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice is unknown.</p></div><div id="S22" class="sec"><h3>Vitamin C normalizes several <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mouse liver stress markers and limits innate inflammation</h3><p id="P32" class="p p-first">The GSEA on the expression data of livers from <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice suggested the increase in oxidative stress and inflammatory responses were reversed by ascorbate treatment. We first examined p38 activation, as this marker was also shown to be involved in senescence of WS fibroblasts (<a href="#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018517">51</a>). A proportional increase in p38 expression and phosphorylation levels was noted in the liver of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals compared to WT mice, but ascorbate had no effect on these changes (<a href="/pmc/articles/PMC3712979/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7<em>A&#x02013;C</em></span></a>). We also examined JNK and TNF-&#x003b1; stress markers, but no significant change was seen in their expression and/or activation status between WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (data not shown).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F7" co-legend-rid="lgnd_F7"><a href="/pmc/articles/PMC3712979/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139897557886528" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f7.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f7.jpg" src="/pmc/articles/PMC3712979/bin/nihms3020f7.jpg" /></div><div id="largeobj_idm139897557886528" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3712979/figure/F7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F7"><div><a class="figpopup" href="/pmc/articles/PMC3712979/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7">Figure 7</a></div><!--caption a7--><div class="caption"><p id="__p8">Effect of ascorbate on liver stress markers of WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated (since weaning) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>A</em>) Western blot showing expression of p38 in liver tissues of 9-mo-old mice. &#x003b2;-Tubulin is used as loading control. <em>B</em>) Scanning analyses of Western blots, expressed as ratio of p38 signal to &#x003b2;-tubulin signal. Bars represent means &#x000b1; SE. *<em>P</em> &#x0003c; 0.05 <em>vs.</em> WT; unpaired <em>t</em> test. <em>C</em>) Phosphorylation of the p38 kinase (pp38) in liver tissues of mice at 9 mo of age. <em>D</em>) Western blots showing levels of phosphorylated NF-&#x003ba;B and total NF-&#x003ba;B proteins in liver tissues of 9-mo-old mice. <em>E</em>) Western blots showing levels of PKC&#x003b4; protein in liver tissues of 9-mo-old mice. &#x003b2;-Tubulin is used as loading control. <em>F</em>) Western blots showing levels of phosphorylated Akt substrates in liver tissues of 9-mo-old mice. &#x003b2;-Tubulin is used as loading control. <em>G</em>) Western blots showing levels of Hif-1&#x003b1; in liver tissues of 9-mo-old mice. &#x003b2;-Tubulin is used as a loading control.</p></div></div></div><p id="P33">The NF-&#x003ba;B transcription factor determines cell response to a wide variety of stresses, including inflammation, and was recently shown to be one of the most strongly age-associated markers (<a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018505">52</a>). As indicated in <a href="/pmc/articles/PMC3712979/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7<em>D</em></span></a>, NF-&#x003ba;B phosphorylation levels were significantly higher in the livers of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice than in those of WT mice. This change was largely prevented by ascorbate treatment (<a href="/pmc/articles/PMC3712979/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7<em>D</em></span></a> and <a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Fig. 3<em>A</em>, <em>B</em></a>).</p><p id="P34">Protein kinase B (PKB/Akt) and C family members are critical upstream regulators of cell survival, metabolism, or inflammation. They regulate NF-&#x003ba;B and are altered in a broad range of diseases (<a href="#R53" rid="R53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018587">53</a>&#x02013;<a href="#R55" rid="R55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018515">55</a>). Therefore, we extended our molecular survey to these factors and examined the expression and activation status of PKC&#x003b1;, &#x003b2;, and &#x003b4;. No differences were noted in PKC&#x003b1; and &#x003b2; protein or phosphorylation levels between WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> liver tissues (data not shown). In contrast, liver PKC&#x003b4; protein levels were ~55% increased in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals (<a href="/pmc/articles/PMC3712979/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7<em>E</em></span></a> and <a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Fig. 3<em>C</em></a>). This result is consistent with the role of PKC&#x003b4; in fatty acid-induced hepatic insulin resistance (<a href="#R56" rid="R56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018553">56</a>). Ascorbate prevented this change in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals and even reduced PKC&#x003b4; levels to values below those of WT mice (<a href="/pmc/articles/PMC3712979/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7<em>E</em></span></a> and <a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Fig. 3<em>C</em></a>). Finally, the overall Akt catalytic activity was assessed by the detection of its endogenous phosphorylated substrates. There was a net increase of Akt activity in the liver of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals (<a href="/pmc/articles/PMC3712979/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7<em>F</em></span></a>), and this change was prevented in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice on ascorbate supplementation (<a href="/pmc/articles/PMC3712979/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7<em>F</em></span></a> and <a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Fig. 3<em>D</em></a>).</p><p id="P35" class="p p-last">It is known that Hif-1&#x003b1; is stabilized under chronic inflammatory conditions or under chronic cellular redox alterations due to accumulation of ROS (<a href="#R57" rid="R57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018599">57</a>, <a href="#R58" rid="R58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018572">58</a>). As shown in <a href="/pmc/articles/PMC3712979/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7<em>G</em></span></a>, Hif-1&#x003b1; protein level was ~5.5-fold higher in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals than WT mice (<a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Fig. 3<em>E</em></a>). Ascorbate treatment decreased this level in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals by 2-fold (<a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Fig. 3<em>E</em></a>). Altogether, these results indicate that ascorbate treatment decreased the activities of several markers associated with oxidative stress and inflammation in the liver of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice.</p></div><div id="S23" class="sec"><h3>PPAR&#x003b1; expression changes on both long-term and short-term ascorbate treatment in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice</h3><p id="P36" class="p p-first-last">Peroxisome proliferator-activated receptor &#x003b1; (PPAR&#x003b1;) is a major upstream regulator of lipid metabolism, and its expression is also modulated by aging (<a href="#R59" rid="R59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018539">59</a>). Microarray analyses indicated that PPAR&#x003b1; expression was increased in ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. Western blot analyses of liver extracts revealed similar PPAR&#x003b1; protein content in WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. In contrast, ascorbate dramatically increased PPAR&#x003b1; expression in mutant animals (<a href="/pmc/articles/PMC3712979/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span>Fig. 8</span></a>). To determine whether a shorter treatment had similar effects on <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice, we supplemented 7-mo-old animals with ascorbate for 8 wk and repeated our measurements. As indicated previously, 7-mo-old <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals already displayed metabolic abnormalities and a severe liver sinusoidal endothelial defenestration (<a href="/pmc/articles/PMC3712979/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2<em>C</em></span></a>). An 8-wk ascorbate treatment led to refenestration of the liver sinusoidal endothelium (<a href="/pmc/articles/PMC3712979/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2<em>F</em></span></a>). Interestingly, liver PPAR&#x003b1; protein level was also significantly increased after 8 wk of ascorbate treatment (<a href="/pmc/articles/PMC3712979/figure/F8/" target="figure" class="fig-table-link figpopup" rid-figpopup="F8" rid-ob="ob-F8" co-legend-rid="lgnd_F8"><span>Fig. 8</span></a>). In contrast, the increased activation and expression of p38, phospho-Akt substrates, Hif-1&#x003b1;, phospho-NF&#x003ba;B, and PKC&#x003b4; were not reversed by a short-term ascorbate treatment (data not shown).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F8" co-legend-rid="lgnd_F8"><a href="/pmc/articles/PMC3712979/figure/F8/" target="figure" rid-figpopup="F8" rid-ob="ob-F8"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139897578408720" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f8.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f8.jpg" src="/pmc/articles/PMC3712979/bin/nihms3020f8.jpg" /></div><div id="largeobj_idm139897578408720" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3712979/figure/F8/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F8"><div><a class="figpopup" href="/pmc/articles/PMC3712979/figure/F8/" target="figure" rid-figpopup="F8" rid-ob="ob-F8">Figure 8</a></div><!--caption a7--><div class="caption"><p id="__p9">Short-term and long-term effect of ascorbate on liver PPAR&#x003b1; in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>A</em>) Examples of Western blots showing levels of PPAR&#x003b1; protein in liver tissues of 9-mo-old WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (treated for 30 or 8 wk before protein extraction). <em>B</em>) Scanning analyses of Western blots, expressed as ratio of PPAR&#x003b1; signal to &#x003b2;-tubulin signal in liver tissues. <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice were treated with ascorbate since the age of 7 mo (8-wk treatment) or since weaning (30-wk treatment). Bars represent means &#x000b1; SE. *<em>P</em> &#x0003c; 0.05 <em>vs.</em> WT; unpaired <em>t</em> test.</p></div></div></div></div><div id="S24" class="sec"><h3>Vitamin C restores the mean life-span defect observed with <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice</h3><p id="P37" class="p p-first-last">We investigated the effect of ascorbate supplementation on the mean life span of our mutant cohort. Strikingly, the ascorbate treatment (since weaning) rescued the mean life-span decrease observed in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (log rank test; <em>P</em>=0.0065), allowing them to reach the same values as WT animals (<a href="/pmc/articles/PMC3712979/figure/F9/" target="figure" class="fig-table-link figpopup" rid-figpopup="F9" rid-ob="ob-F9" co-legend-rid="lgnd_F9"><span>Fig. 9<em>A</em></span></a>). Although the incidence of heart fibrosis and tumor formation was the same between untreated and treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice, the oldest <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mouse died at 26 mo of age, while the oldest ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mouse died at 30 mo of age like the oldest WT animal.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F9" co-legend-rid="lgnd_F9"><a href="/pmc/articles/PMC3712979/figure/F9/" target="figure" rid-figpopup="F9" rid-ob="ob-F9"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139897576626704" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3712979_nihms3020f9.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms3020f9.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3712979/bin/nihms3020f9.jpg" /></a></div><div id="largeobj_idm139897576626704" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3712979/figure/F9/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F9"><div><a class="figpopup" href="/pmc/articles/PMC3712979/figure/F9/" target="figure" rid-figpopup="F9" rid-ob="ob-F9">Figure 9</a></div><!--caption a7--><div class="caption"><p id="__p10">Percentage of disease-free animals with age. <em>A</em>) Comparison of WT, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em>, and ascorbate-treated (since weaning) <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. <em>B</em>) Comparison of untreated and ascorbate-treated (since weaning) WT animals.</p></div></div></div></div><div id="S25" class="sec sec-last"><h3>Vitamin C has no beneficial effect on WT animals</h3><p id="P38" class="p p-first-last">A cohort of WT animals ase also provided with vitamin C, drinking water supplemented daily with 0.4% sodium L-ascorbate (w/v) at weaning. Although ascorbate tended to decrease ROS levels (<a href="#SD4" rid="SD4" class=" supplementary-material">Supplemental Fig. 4<em>A</em></a>) and significantly decreased oxidative DNA damage in the liver of 9-mo-old WT animals (<a href="#SD4" rid="SD4" class=" supplementary-material">Supplemental Fig. 4<em>B</em></a>), it did not increase their mean life span. Ascorbate had no significant beneficial effect on fat tissues, blood triglyceride, glucose, or insulin resistance (<a href="#SD4" rid="SD4" class=" supplementary-material">Supplemental Fig. 4<em>C</em>&#x02013;<em>H</em></a>). Furthermore, ascorbate did not increase PPAR&#x003b1; expression in the liver of WT mice and had no effect on the expression of liver p38 kinase, phospho-Akt substrates, NF-&#x003ba;B, Hif-1&#x003b1;, and PKC&#x003b4; (data not shown).</p></div></div><div id="S26" class="tsec sec"><h2 class="head no_bottom_margin" id="S26title">DISCUSSION</h2><div id="S27" class="sec sec-first"><h3>Mouse model</h3><p id="P39" class="p p-first">The study of the age-associated biological defects relies on animal models that closely mimic the clinical setting. One of the numerous consequences of aging is the appearance of metabolic syndrome. Our mouse model, the <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mutant mice, prematurely develops most of the symptoms associated with normal human aging and mimics the human WS. These mice exhibit increased blood insulin, glucose, triglycerides, cholesterol, hyaluronic acid, systemic ROS, heart failure, and different types of cancers (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018570">13</a>). The <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mutant mouse contains a deletion in part of the helicase domain of the Wrn protein (<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018601">11</a>). These mice synthesize a stable mutant protein with no DNA helicase activity. This is apparently different from humans with WS, who neither synthesize a stable WRN protein nor produce a truncated WRN protein that cannot translocate to the nucleus. As such, patients with WS are considered null mutants (<a href="#R60" rid="R60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018569">60</a>). Although most <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice do not die prematurely (for example, before the age of 12 mo), the mean life span of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mouse cohort is significantly reduced compared to WT animals. This is in contrast to <em>Wrn</em>-null animals that do not have a reduced life span (<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018534">14</a>) or develop metabolic syndrome (such as hyperglycemia and hyperinsulinemia) unless given a high-carbohydrate diet (<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018522">15</a>). The reason for the difference between <em>Wrn-</em>null and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice is unknown. Although we cannot rule out the possibility that a DNA helicase mutant Wrn protein could act as a dominant-negative peptide, this Wrn mutant protein does not associate with the DNA replication complex like the normal protein (<a href="#R61" rid="R61" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018535">61</a>). Experiments are currently under way to determine whether the helicase mutant Wrn protein can interact and affect the enzymatic activity of known Wrn protein partners.</p><p id="P40" class="p p-last">In addition to the observed metabolic abnormalities, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice have increased circulating ascorbate levels like humans with WS (<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018556">29</a>). Every organ extract from mutant mice that we examined had an increased ascorbate level. <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice also secreted less ascorbate in their urine than WT animals. Interestingly, blood ascorbate levels increased with phenotypic progression in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. Ascorbate being protective, it is possible that the retention of vitamin C is a defense mechanism to counterbalance the age-dependent rise in oxidative stress. We cannot rule out, however, the possibility that the increased ascorbate levels observed in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice are due to a modification in ascorbate metabolism only specific to these mice. Interestingly, blood ascorbate levels are 2-fold higher in patients with WS compared to other patients with segmental progeroid syndrome, such as patients with Bloom syndrome, ataxia telangectasia, Down syndrome, Fanconi anemia, and xeroderma pigmentosum (<a href="#R62" rid="R62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018541">62</a>). The molecular mechanism by which <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice retain ascorbate in their liver, for example, is unknown. Microarray analyses of liver tissues between WT and <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice did not indicate significant expression changes in pathways involved in ascorbate metabolism or transportation. Accordingly, expression of enzymes directly involved in ascorbate synthesis (SMP30 and Gulo gene products) and the activity of enzymes involved in ascorbate metabolism (thioredoxin reductase and cytochrome-b5-reductase) were not changed in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice compared to WT animals. Finally, the protein levels of the ascorbate transporter SVCT1 in the liver and kidneys were similar in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> and WT mice. It is possible, however, that post-translational modification of key components of ascorbate transport are affecting their activities in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. Thorough proteomic analyses will be required to resolve this issue.</p></div><div id="S28" class="sec"><h3>GSEA on liver tissues indicate increased oxidative stress and inflammatory response in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice</h3><p id="P41" class="p p-first-last">GSEA on the liver of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice revealed changes in the expression of genes involved in xenobiotic and glutathione metabolisms, caloric restriction, and inflammation. Although blood GSH levels were lower in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice than WT animals, the increased glutathione metabolism pathway in liver helped these mice to maintain hepatic GSH levels above normal. Again, such findings indicate that <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice may be up-regulating the necessary pathways to survive. Correspondingly, it was reported that these so-called shared longevity assurance pathways are similarly altered in both delayed and accelerated aging mouse models (<a href="#R63" rid="R63" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018586">63</a>, <a href="#R64" rid="R64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018576">64</a>). However, the alteration in these pathways and the greater retention of ascorbate were insufficient for <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice to maintain a healthy life. As already mentioned, blood GSH levels in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mutant mice were still lower than in normal mice, and mutant mice developed all of the metabolic traits associated with human WS (such as dyslipidemia, hyperglycemia, hyperinsulinemia). Furthermore, liver tissues from <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice exhibited increased expression and phosphorylation of the stress markers phospho-p38 kinase, phospho-Akt substrates, phospho-NF&#x003ba;B, phospho-PKC&#x003b4;, and Hif-1&#x003b1;. Finally, the mean life span of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice were reduced compared to WT animals. Interestingly, <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice exhibited a severe premature liver sinusoidal endothelial defenestration at 7 mo of age (<a href="/pmc/articles/PMC3712979/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>). Such defenestration is normally observed in much older animals (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018531">18</a>). The defenestration corresponded to the onset of diabetes in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018592">13</a>). Finally, several older <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice developed liver tumors, which is consistent with the gene expression changes observed in the microarray studies.</p></div><div id="S29" class="sec"><h3>Vitamin C has a beneficial effect on <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice but not on WT animals</h3><p id="P42" class="p p-first">Because increased ROS was observed prior to any of the metabolic changes measured in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018593">13</a>), we decided to treat mutant mice with suprapharmacological levels of vitamin C based on a previous study on the beneficial effect of ascorbate on mice unable to synthesize vitamin C (<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018551">20</a>). Note that the decision of using vitamin C was taken before we performed blood ascorbate measurements. To our knowledge, this is the first report showing that vitamin C is beneficial in a mouse model for WS. A daily ascorbate supplementation allowed <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice to recover a normal mean life span and healthy aging. Although the number of animals used in each cohort was not big enough for a statistical testing on maximum life span (<a href="#R65" rid="R65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018519">65</a>), ascorbate treatment did prevent the appearance of WS characteristic redox imbalance and related genomic damage. It also prevented the liver proinflammatory status observed in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. A normalization of phospho-Akt substrates, phospho- NF-&#x003ba;B, phospho-PKC&#x003b4;, and Hif-1&#x003b1; levels was obtained with the treatment. In addition, ascorbate supplementation dramatically improved the metabolic profile of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> animals, although the lack of change in liver steatosis (as defined by total lipid levels) was a curious exception (data not shown). These metabolic improvements were paralleled by an increased expression of the homeostasis regulator PPAR&#x003b1; and by a complete refenestration of the sinusoidal endothelium in treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> -mouse livers. PPAR&#x003b1; activation is known to cause lipid clearance <em>via</em> &#x003b2;-oxidation enhancement and exerts anti-inflammatory effects on both the vascular wall and the liver (<a href="#R66" rid="R66" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018544">66</a>). Finally, the increase in ascorbate levels in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice was insufficient to stabilize GSH levels. Implementation of suprapharmacological amounts of ascorbate was required to normalize GSH levels in blood and tissues of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice.</p><p id="P43">Vitamin C only induced a trend in reducing the number of mitochondrial DNA mutations in liver tissues of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. This is not surprising, as mice were treated with ascorbate at weaning. Mitochondrial DNA mutations could have accumulated during embryogenesis and before weaning in such tissues of mutant mice. Vitamin C cannot reverse mutations once fixed in mitochondrial DNA.</p><p id="P44" class="p p-last">In contrast to <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice, ascorbate had no beneficial effects on the health or mean life span of WT animals. Even though oxidative DNA damage was reduced significantly in the liver of ascorbate-treated WT mice, the expression and activation of oxidative stress and inflammatory response markers did not change. Thus, the beneficial effect of vitamin C could only be seen with <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. These results suggest that vitamin C supplementation would be a very relevant regimen to alleviate abnormal cellular functions associated with WS only. However, additional testing will be required on <em>Wrn</em>-null mice lacking telomerase activity, which exhibits a more severe premature aging phenotype related to WS (<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018575">16</a>), to determine its beneficial effect. Ascorbate treatments on other progeroid mouse models will also be required to determine whether it can alleviate several age-related syndromes.</p></div><div id="S30" class="sec"><h3>GSEA of vitamin C-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice reveals changes in pathways associated with the immune system, stem cell maturation, and adipocyte differentiation</h3><p id="P45" class="p p-first-last">The first remarkable set of liver genes affected by ascorbate is the one known to be up-regulated in human WS fibroblast. Ascorbate significantly inhibited genes that have been shown to be up-regulated in human WS fibroblasts (<a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018602">38</a>) (<a href="/pmc/articles/PMC3712979/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5<em>B</em></span></a>). Ascorbate also down-regulated pathways normally up-regulated in cancers exhibiting increased Myc or Myb transcriptional activities (<a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018546">35</a>, <a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018577">39</a>). In addition, pathways related to several types of tissue injury response were up-regulated by ascorbate. Concomitantly, ascorbate altered biological pathways related to stem-cell maturation. It is unknown at this point whether this maturation is entirely related to the immune system associated with the liver tissue, or the replacement of abnormal sinusoidal endothelial cells and/or to the renewal of hepatocytes. Although refenestration of the sinusoidal endothelium points to endothelial maturation, thorough examination of each cellular compartment in the liver with the appropriate techniques will indicate which cell type is rejuvenated with vitamin C in this mouse model. Regardless of future results, our observations indicate that vitamin C stimulated a positive response for liver tissue renewal (<em>e.g.</em>, refenestration) and slowed WS senescence-associated gene expression (<a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018550">38</a>). Finally, ascorbate up-regulated genes normally involved in dedifferentiation of adipocytes in obese mice (<a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018600">40</a>). This GSEA result is also consistent with the observation that <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice lose weight and visceral fat tissue on exposure to vitamin C. It is noteworthy that ascorbate-treated <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice drank and ate as much water and food as untreated or WT animals.</p></div><div id="S31" class="sec sec-last"><h3>Short-term ascorbate treatment reversed liver endothelium defenestration and normalized several metabolic abnormalities, even in the presence of a significant oxidative stress</h3><p id="P46" class="p p-first">Although ROS scavenging would be a mechanism by which vitamin C could indirectly affect gene expression (ROS can also be used as a second messenger of several signal transduction pathways), the short-term treatment indicated another potential mechanism for gene regulation. Metabolic normalization, PPAR&#x003b1; induction, and liver sinusoidal endothelial refenestration in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice were readily observable on a short 8-wk treatment with vitamin C. This occurred even in the presence of significant amounts of ROS and oxidative DNA damage in liver tissues. It is worthy to note that activation and overexpression of stress markers such as p38 kinase, phospho-Akt, phospho- NF-&#x003ba;B, and PKC&#x003b4; were still up-regulated after an 8-wk treatment. These results suggest that PPAR&#x003b1; could be a target molecule to revert liver sinusoidal endothelial defenestration in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice and ameliorate lipid as well as glucose metabolism. Interestingly, a recent report has indicated that an agonist of another member of this family of transcription factor, PPAR&#x003b3;, ameliorated insulin resistance, glucose, and lipid metabolism and decreased the inflammatory marker IL-6 in several patients with WS (<a href="#R67" rid="R67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018540">67</a>, <a href="#R68" rid="R68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018543">68</a>). The agonist also increased the median life span of several patients with WS (<a href="#R69" rid="R69" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018580">69</a>). Treatment of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice with PPAR&#x003b1; agonists is under way to assess their effect on liver sinusoid endothelial fenestration.</p><p id="P47" class="p p-last">The exact mechanism by which vitamin C alters gene expression is currently unknown. It is less clear how PPAR&#x003b1; expression is increased in <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice but not in WT animals. Notably, ascorbate can be used by cells as a cofactor for a family of dioxygenase enzymes. An important class of enzymes that directly affects the activity of several transcription factors is the prolyl hydroxylase. Hydroxylation of prolyl residues on Hif-1&#x003b1; will induce its polyubiquitination and its proteosomal degradation (<a href="#R57" rid="R57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018547">57</a>, <a href="#R58" rid="R58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018574">58</a>). On one hand, ROS will stabilize Hif-1&#x003b1;, as seen in the liver of <em>Wrn</em><sup>&#x00394;</sup><em><sup>hel/</sup></em><sup>&#x00394;</sup><em><sup>hel</sup></em> mice. On the other hand, large implementation of ascorbate may increase cellular prolyl hydroxylase activities and hence Hif-1&#x003b1; degradation, as seen in vitamin C-treated mutant mice. Recently, several reports indicated that the same hydroxylases that alter the Hif pathway may also regulate important components of the NF-&#x003ba;B pathway (<a href="#R58" rid="R58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018536">58</a>). Furthermore, there are several other transcription factors that can be directly or indirectly activated by prolyl hydroxylases or by the cellular redox status. Such transcription factors include Hif-1&#x003b1;, NF-&#x003ba;B, AP-1 (Fos/Jun), CREB, GATA-2, p53, Sp-1, C/EBP&#x003b2;, certain Ets family members, Gadd153, and NF-IL-6 (<a href="#R58" rid="R58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018510">58</a>). The next step will be to examine the role of prolyl hydroxylases in our mouse model treated with or without vitamin C and to identify the transcription factors that affect the pathways leading to the WS phenotypes.</p></div></div><div id="S32" class="tsec sec"><h2 class="head no_bottom_margin" id="S32title">CONCLUSIONS</h2><p id="P48" class="p p-first-last">The present study is the first to demonstrate that treatment of a mouse model phenocopying many aspects of the human WS with vitamin C reverses most of the phenotypes associated with this syndrome. We also show that such Wrn-mutant mice exhibit a severe premature defenestration of their liver sinusoidal endothelial cells, a phenotype usually associated with old age in different animal models (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_664018573">18</a>). Long-term (since weaning) and short-term (8 wk) treatments of vitamin C reversed the liver sinusoidal endothelial defenestration phenotype. Notably, the major upstream regulator of lipid metabolism PPAR&#x003b1; was increased by both long-and short-term treatments. Finally, vitamin C (or ascorbate) increased the mean life span of our Wrn mutant mice. In contrast, vitamin C had no beneficial effect on the health of WT animals. Our results suggest that long-term vitamin C supplementation could have beneficial effects for patients with WS.</p></div><div id="S36" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="S36title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>Figure S1</h4><div class="sup-box half_rhythm" id="d36e3425"><a href="/pmc/articles/PMC3712979/bin/NIHMS3020-supplement-FigS1.pdf">Click here to view.</a><sup>(155K, pdf)</sup></div></div><div class="sec suppmat" id="SD2"><h4>Figure S2</h4><div class="sup-box half_rhythm" id="d36e3429"><a href="/pmc/articles/PMC3712979/bin/NIHMS3020-supplement-FigS2.pdf">Click here to view.</a><sup>(286K, pdf)</sup></div></div><div class="sec suppmat" id="SD3"><h4>Figure S3</h4><div class="sup-box half_rhythm" id="d36e3433"><a href="/pmc/articles/PMC3712979/bin/NIHMS3020-supplement-FigS3.pdf">Click here to view.</a><sup>(237K, pdf)</sup></div></div><div class="sec suppmat" id="SD4"><h4>Figure S4</h4><div class="sup-box half_rhythm" id="d36e3437"><a href="/pmc/articles/PMC3712979/bin/NIHMS3020-supplement-FigS4.pdf">Click here to view.</a><sup>(208K, pdf)</sup></div></div><div class="sec suppmat" id="SD5"><h4>Table S1</h4><div class="sup-box half_rhythm" id="d36e3441"><a href="/pmc/articles/PMC3712979/bin/NIHMS3020-supplement-TableS1.xls">Click here to view.</a><sup>(101K, xls)</sup></div></div><div class="sec suppmat" id="SD6"><h4>Table S2</h4><div class="sup-box half_rhythm" id="d36e3445"><a href="/pmc/articles/PMC3712979/bin/NIHMS3020-supplement-TableS2.xls">Click here to view.</a><sup>(75K, xls)</sup></div></div><div class="sec suppmat" id="SD7"><h4>Table S5</h4><div class="sup-box half_rhythm" id="d36e3449"><a href="/pmc/articles/PMC3712979/bin/NIHMS3020-supplement-TableS5.xls">Click here to view.</a><sup>(52K, xls)</sup></div></div></div><div id="S33" class="tsec sec"><h2 class="head no_bottom_margin" id="S33title">Acknowledgments</h2><div class="sec"><p id="__p1">We thank Dr. O. Neyret-Djossou of the functional genomic platform of the Institut de Recherche Clinique de Montreal (Montreal, QC, Canada) for the microarray services. We are also grateful to M. Sild and A. Labb&#x000e9; for real-time RT-PCRs (Centre de Recherche en Canc&#x000e9;rologie de l&#x02019;Universit&#x000e9; Laval). This work was supported in part by grants from the Canadian Institutes of Health Research and from the National Sciences and Engineering Research Council of Canada to M.L. and from The National Health and Medical Research Council of Australia and from the Aging and Alzheimers Research Foundation (a Division of the Medical Foundation of the University of Sydney) to D.G.L. M.L. is a senior scholar of the Fonds de la Recherche en Sant&#x000e9; du Qu&#x000e9;bec.</p></div></div><div id="idm139897575302576" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139897575302576title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Kipling D, Davis T, Ostler EL, Faragher RGA. What can progeroid syndromes tell us about human aging? <span><span class="ref-journal">Science. </span>2004;<span class="ref-vol">305</span>:1426–1431.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15353794" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Epstein CJ, Martin GM, Schultz AL, Motulsky AG. Werner&#x02019;s syndrome: a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. <span><span class="ref-journal">Medicine. </span>1966;<span class="ref-vol">45</span>:177–221.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/5327241" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Salk D. Werner&#x02019;s syndrome: a review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations. <span><span class="ref-journal">Hum Genet. </span>1982;<span class="ref-vol">62</span>:1–5.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/6759366" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Yu C, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD. Positional cloning of the Werner&#x02019;s syndrome gene. <span><span class="ref-journal">Science. </span>1996;<span class="ref-vol">272</span>:258–262.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/8602509" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Ozgenc A, Loeb LA. Current advances in unraveling the function of the Werner syndrome protein. <span><span class="ref-journal">Mutat Res. </span>2005;<span class="ref-vol">577</span>:237–251.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15946710" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Balajee AS, Machwe A, May A, Gray MD, Oshima J, Martin GM, Nehlin JO, Brosh R, Orren DK, Bohr VA. The Werner syndrome protein is involved in RNA polymerase II transcription. <span><span class="ref-journal">Mol Biol Cell. </span>1999;<span class="ref-vol">10</span>:2655–2668.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC25497/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10436020" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Cooper MP, Machwe A, Orren DK, Brosh RM, Ramsden D, Bohr VA. Ku complex interacts with and stimulates the Werner protein. <span><span class="ref-journal">Genes Dev. </span>2000;<span class="ref-vol">4</span>:907–912.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC316545/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10783163" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Shen JC, Loeb LA. The Werner syndrome gene: the molecular basis of RecQ helicase-deficiency diseases. <span><span class="ref-journal">Trends Genet. </span>2000;<span class="ref-vol">16</span>:213–220.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10782115" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Saintigny Y, Makienko K, Swanson C, Emond MJ, Monnat RJ., Jr Homologous recombination resolution defect in Werner Syndrome. <span><span class="ref-journal">Mol Cell Biol. </span>2002;<span class="ref-vol">22</span>:6971–6978.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC139822/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12242278" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Crabbe L, Verdun RE, Haggblom CI, Karlseder J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. <span><span class="ref-journal">Science. </span>2004;<span class="ref-vol">306</span>:1951–1953.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15591207" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Lebel M, Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1998;<span class="ref-vol">95</span>:13097–13102.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC23722/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9789047" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Lebel M, Lavoie J, Gaudreault I, Bronsard M, Drouin R. Genetic cooperation between the Werner syndrome protein and poly(ADPribose) polymerase-1 in preventing chromatid breaks, complex chromosomal rearrangements, and cancer in mice. <span><span class="ref-journal">Am J Pathol. </span>2003;<span class="ref-vol">162</span>:1559–1569.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1851180/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12707040" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Massip L, Garand C, Turaga RV, Desch&#x000ea;nes F, Thorin E, Lebel M. Increased insulin, triglycerides, reactive oxygen species, and cardiac fibrosis in mice with a mutation in the helicase domain of the Werner syndrome gene homologue. <span><span class="ref-journal">Exp Gerontol. </span>2006;<span class="ref-vol">41</span>:157–168.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16330174" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, Bronson R, Buhlmann JE, Lipman R, Curry R, Sharpe A, Jaenisch R, Guarente L. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. <span><span class="ref-journal">Mol Cell Biol. </span>2000;<span class="ref-vol">20</span>:3286–3291.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC85622/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10757812" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Moore G, Knoblaugh S, Gollahon K, Rabinovitch P, Ladiges W. Hyperinsulinemia and insulin resistance in Wrn null mice fed a diabetogenic diet. <span><span class="ref-journal">Mech Aging Dev. </span>2008;<span class="ref-vol">129</span>:201–206.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2706000/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18295300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Chang S, Multani AS, Cabrera NG, Naylor ML, Laud P, Lombard D, Pathak S, Guarente L, DePinho RA. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:877–882.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15235603" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. <span><span class="ref-journal">Lancet. </span>2005;<span class="ref-vol">365</span>:1415–1428.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15836891" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Le Couteur DG, Warren A, Cogger VC, Smedsr&#x000f8;d B, S&#x000f8;rensen KK, De Cabo R, Fraser R, McCuskey RS. Old age and the hepatic sinusoid. <span><span class="ref-journal">Anat Rec (Hoboken) </span>2008;<span class="ref-vol">291</span>:672–683.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18484614" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Hilmer SN, Cogger VC, Fraser R, McLean AJ, Sullivan D, Le Couteur DG. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. <span><span class="ref-journal">Hepatology. </span>2005;<span class="ref-vol">42</span>:1349–1354.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16317689" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Maeda N, Hagihara H, Nakata Y, Hiller S, Wilder J, Reddick R. Aortic wall damage in mice unable to synthesize ascorbic acid. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2000;<span class="ref-vol">97</span>:841–846.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC15418/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10639167" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. <span><span class="ref-journal">Diabetologia. </span>1985;<span class="ref-vol">28</span>:412–419.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/3899825" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C, Prolla TA. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. <span><span class="ref-journal">Science. </span>2005;<span class="ref-vol">309</span>:481–484.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16020738" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Warren A, Bertolino P, Cogger VC, McLean AJ, Fraser R, Le Couteur DG. Hepatic pseudocapillarization in aged mice. <span><span class="ref-journal">Exp Gerontol. </span>2005;<span class="ref-vol">40</span>:807–812.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16125353" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Desch&#x000ea;nes F, Massip L, Garand C, Lebel M. In vivo misregulation of genes involved in apoptosis, development and oxidative stress in mice lacking both functional Werner syndrome protein and poly(ADP-ribose) polymerase-1. <span><span class="ref-journal">Hum Mol Genet. </span>2005;<span class="ref-vol">14</span>:3293–3308.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16195394" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2005;<span class="ref-vol">102</span>:15545–15550.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1239896/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16199517" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Kondo Y, Inai Y, Sato Y, Handa S, Kubo S, Shimokado K, Goto S, Nishikimi M, Maruyama N, Ishigami A. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:5723–5728.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1458640/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16585534" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Sottocasa GC, Kuylenstierna B, Ernster L, Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria. <span><span class="ref-journal">J Cell Biol. </span>1967;<span class="ref-vol">32</span>:415–438.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2107253/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10976232" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Borgese N, Pietrini G. Distribution of the integral membrane protein NADH-cytochrome b5 reductase in rat liver cells, studied with a quantitative radioimmunoblotting assay. <span><span class="ref-journal">Biochem J. </span>1986;<span class="ref-vol">239</span>:393–403.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1147293/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/3814080" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Pagano G, Zatterale A, Degan P, d&#x02019;Ischia M, Kelly FJ, Pallard&#x000f3; FV, Calzone R, Castello G, Dunster C, Giudice A, Kilin&#x000e7; Y, Lloret A, Manini P, Masella R, Vuttariello E, Warnau M. In vivo prooxidant state in Werner syndrome (WS): results from three WS patients and two WS heterozygotes. <span><span class="ref-journal">Free Radic Res. </span>2005;<span class="ref-vol">39</span>:529–533.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16036329" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Otsuka M, Matsuzawa M, Ha TY, Arakawa N. Contribution of a high dose of L-ascorbic acid to carnitine synthesis in guinea pigs fed high-fat diets. <span><span class="ref-journal">J Nutr Sci Vitaminol (Tokyo) </span>1999;<span class="ref-vol">45</span>:163–171.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10450557" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Massie HR, Aiello VR, Doherty TJ. Dietary vitamin C improves the survival of mice. <span><span class="ref-journal">Gerontology. </span>1984;<span class="ref-vol">30</span>:371–375.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/6519438" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Kashino G, Kodama S, Nakayama Y, Suzuki K, Fukase K, Goto M, Watanabe M. Relief of oxidative stress by ascorbic acid delays cellular senescence of normal human and Werner syndrome fibroblast cells. <span><span class="ref-journal">Free Radic Biol Med. </span>2003;<span class="ref-vol">35</span>:438–443.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12899945" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Mori S, Murano S, Yokote K, Takemoto M, Asaumi S, Take A, Saito Y. Enhanced intra-abdominal visceral fat accumulation in patients with Werner&#x02019;s syndrome. <span><span class="ref-journal">Int J Obes Relat Metab Disord. </span>2001;<span class="ref-vol">25</span>:29229–29225.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11410834" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Bokko PB, Francione L, Bandala-Sanchez E, Ahmed AU, Annesley SJ, Huang X, Khurana T, Kimmel AR, Fisher PR. Diverse cytopathologies in mitochondrial disease are caused by AMP-activated protein kinase signaling. <span><span class="ref-journal">Mol Biol Cell. </span>2007;<span class="ref-vol">18</span>:1874–1886.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1855013/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17332500" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Lee JS, Chu IS, Mikaelyan A, Calvisi DF, Heo J, Reddy JK, Thorgeirsson SS. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:1306–1311.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15565109" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. <span><span class="ref-journal">Science. </span>1999;<span class="ref-vol">285</span>:1390–1393.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10464095" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Zhu H, Cong JP, Mamtora G, Gingeras T, Shenk T. Cellular gene expression altered by human cytomegalo-virus: global monitoring with oligonucleotide arrays. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1998;<span class="ref-vol">95</span>:14470–14475.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC24397/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9826724" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Kyng KJ, May A, K&#x000f8;lvraa S, Bohr VA. Gene expression profiling in Werner syndrome closely resembles that of normal aging. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:12259–12264.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC218746/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/14527998" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Shepard JL, Amatruda JF, Stern HM, Subramanian A, Finkelstein D, Ziai J, Finley KR, Pfaff KL, Hersey C, Zhou Y, Barut B, Freedman M, Lee C, Spitsbergen J, Neuberg D, Weber G, Golub TR, Glickman JN, Kutok JL, Aster JC, Zon LI. A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2005;<span class="ref-vol">102</span>:13194–13199.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1198999/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16150706" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, Attie AD. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2000;<span class="ref-vol">97</span>:11371–11376.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC17207/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11027337" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Yu D, Cozma D, Park A, Thomas-Tikhonenko A. Functional validation of genes implicated in lymphomagenesis: an in vivo selection assay using a Myc-induced B-cell tumor. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2005;<span class="ref-vol">1059</span>:145–159.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1490324/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16382050" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Ichiba T, Teshima T, Kuick R, Misek DE, Liu C, Takada Y, Maeda Y, Reddy P, Williams DL, Hanash SM, Ferrara JL. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. <span><span class="ref-journal">Blood. </span>2003;<span class="ref-vol">102</span>:763–771.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12663442" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Flechner SM, Kurian SM, Head SR, Sharp SM, Whisenant TC, Zhang J, Chismar JD, Horvath S, Mondala T, Gilmartin T, Cook DJ, Kay SA, Walker JR, Salomon DR. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. <span><span class="ref-journal">Am J Transplant. </span>2004;<span class="ref-vol">4</span>:1475–1489.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2041877/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15307835" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2004;<span class="ref-vol">101</span>:6669–6674.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC404103/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15100412" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation">McLachlan JL, Smith AJ, Bujalska IJ, Cooper PR. Gene expression profiling of pulpal tissue reveals the molecular complexity of dental caries. <span><span class="ref-journal">Biochim Biophys Acta. </span>2005;<span class="ref-vol">1741</span>:271–281.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15869869" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="element-citation">Hoffmann R, Seidl T, Neeb M, Rolink A, Melchers F. Changes in gene expression profiles in developing B cells of murine bone marrow. <span><span class="ref-journal">Genome Res. </span>2002;<span class="ref-vol">12</span>:98–111.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC155249/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11779835" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="element-citation">Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA. &#x0201c;Stemness&#x0201d;: transcriptional profiling of embryonic and adult stem cells. <span><span class="ref-journal">Science. </span>2002;<span class="ref-vol">298</span>:597–600.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12228720" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">48. <span class="element-citation">Villalba JM, Navas P. Plasma membrane redox system in the control of stress-induced apoptosis. <span><span class="ref-journal">Antioxid Redox Signal. </span>2000;<span class="ref-vol">2</span>:213–230.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11229527" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">49. <span class="element-citation">Linster CL, Van Schaftingen E. Vitamin C. Biosynthesis, recycling and degradation in mammals. <span><span class="ref-journal">FEBS J. </span>2007;<span class="ref-vol">274</span>:1–22.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17222174" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R50">50. <span class="element-citation">Kuo SM, MacLean ME, McCormick K, Wilson JX. Gender and sodium-ascorbate transporter isoforms determine ascorbate. <span><span class="ref-journal">J Nutr. </span>2004;<span class="ref-vol">134</span>:2216–2221.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15333707" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R51">51. <span class="element-citation">Davis T, Baird DM, Haughton MF, Jones CJ, Kipling D. Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. <span><span class="ref-journal">J Gerontol A Biol Sci Med Sci. </span>2005;<span class="ref-vol">60</span>:1386–1393.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16339323" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R52">52. <span class="element-citation">Adler AS, Sinha S, Kawahara TL, Zhang JY, Segal E, Chang HY. Motif module map reveals enforcement of aging by continual NF-&#x003ba;B activity. <span><span class="ref-journal">Genes Dev. </span>2007;<span class="ref-vol">21</span>:3244–3257.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2113026/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18055696" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R53">53. <span class="element-citation">Hsieh CC, Papaconstantinou J. Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice. <span><span class="ref-journal">FASEB J. </span>2006;<span class="ref-vol">20</span>:259–268.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1479092/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16449798" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R54">55. <span class="element-citation">Hotamisligil GS. Inflammation and metabolic disorders. <span><span class="ref-journal">Nature. </span>2006;<span class="ref-vol">444</span>:860–867.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17167474" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R55">55. <span class="element-citation">Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. <span><span class="ref-journal">Cell. </span>2007;<span class="ref-vol">129</span>:1261–1274.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2756685/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17604717" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R56">56. <span class="element-citation">Lam TK, Yoshii H, Haber CA, Bogdanovic E, Lam L, Fantus IG, Giacca A. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. <span><span class="ref-journal">Am J Physiol Endocrinol Metab. </span>2002;<span class="ref-vol">283</span>:E682–E691.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12217885" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R57">57. <span class="element-citation">Cummins EP, Taylor CT. Hypoxia-responsive transcription factors. <span><span class="ref-journal">Pfl&#x000fc;gers Arch. </span>2005;<span class="ref-vol">450</span>:363–371.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16007431" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R58">58. <span class="element-citation">Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-&#x003ba;B in hypoxic inflammation. <span><span class="ref-journal">J Physiol. </span>2008;<span class="ref-vol">586</span>:4055–4059.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2652186/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18599532" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R59">59. <span class="element-citation">Masternak MM, Bartke A. PPARs in calorie restricted and genetically long-lived mice [Online] <span><span class="ref-journal">PPAR Res. </span>2007;<span class="ref-vol">28436</span> doi: 10.1155/2007/28436.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1779582/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17389764" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1155%2F2007%2F28436" target="pmc_ext" ref="reftype=other&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R60">60. <span class="element-citation">Huang S, Lee L, Hanson NB, Lenaerts C, Hoehn H, Poot M, Rubin CD, Chen DF, Yang CC, Juch H, Dorn T, Spiegel R, Oral EA, Abid M, Battisti C, Lucci-Cordisco E, Neri G, Steed EH, Kidd A, Isley W, Showalter D, Vittone JL, Konstantinow A, Ring J, Meyer P, Wenger SL, von Herbay A, Wollina U, Schuelke M, Huizenga CR, Leistritz DF, Martin GM, Mian IS, Oshima J. The spectrum of WRN mutations in Werner syndrome patients. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:558–567.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1868417/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16673358" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R61">61. <span class="element-citation">Lebel M, Spillare EA, Harris CC, Leder P. Werner syndrome gene product co-purifies with the DNA replication complex and interact with PCNA and topoisomerase I. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:37795–37799.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10608841" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R62">62. <span class="element-citation">Lloret A, Calzone R, Dunster C, Manini P, d&#x02019;Ischia M, Degan P, Kelly FJ, Pallardo FV, Zatterale A, Pagano G. Different patterns of in vivo pro-oxidant states in a set of cancer- or aging-related genetic diseases. <span><span class="ref-journal">Free Rad Biol Med. </span>2008;<span class="ref-vol">44</span>:495–503.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18053816" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R63">63. <span class="element-citation">Swindell WR. Gene expression profiling of long-lived dwarf mice: longevity-associated genes and relationships with diet, gender and aging. <span><span class="ref-journal">BMC Genomics. </span>2007;<span class="ref-vol">8</span>:353–374.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2094713/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17915019" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R64">64. <span class="element-citation">Schumacher B, van der Pluijm I, Moorhouse MJ, Kosteas T, Robinson AR, Suh Y, Breit TM, van Steeg H, Niedernhofer LJ, van Ijcken W, Bartke A, Spindler SR, Hoeijmakers JH, van der Horst GT, Garinis GA. Delayed and accelerated aging share common longevity assurance mechanisms. <span><span class="ref-journal">PLoS Genet. </span>2008;<span class="ref-vol">4</span>:e1000161.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2493043/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18704162" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R65">65. <span class="element-citation">Wang C, Li Q, Redden DT, Weindruch R, Allison DB. Statistical methods for testing effects on &#x0201c;maximum lifespan. <span><span class="ref-journal">Mech Ageing Dev. </span>2004;<span class="ref-vol">125</span>:629–632.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15491681" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R66">66. <span class="element-citation">Zandbergen F, Plutzky J. PPAR&#x003b1; in atherosclerosis and inflammation. <span><span class="ref-journal">Biochim Biophys Acta. </span>2007;<span class="ref-vol">1771</span>:972–982.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2083576/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17631413" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R67">67. <span class="element-citation">Yamamoto H, Kurebayashi S, Kouhara H, Yoshiuchi K, Matsuhisa M, Yamasaki Y, Kasayama S. Impacts of long-term treatments with testosterone replacement and pioglitazone on glucose and lipid metabolism in male patients with Werner&#x02019;s syndrome. <span><span class="ref-journal">Clin Chim Acta. </span>2007;<span class="ref-vol">379</span>:167–170.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17306780" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R68">68. <span class="element-citation">Honjo S, Yokote K, Fujishiro T, Maezawa Y, Sato S, Koshizaka M, Saito Y. Early amelioration of insulin resistance and reduction of interleukin-6 in Werner syndrome using pioglitazone. <span><span class="ref-journal">J Am Geriatr Soc. </span>2008;<span class="ref-vol">56</span>:173–174.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18184212" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R69">69. <span class="element-citation">Yokote K, Saito Y. Extension of the life span in patients with Werner syndrome. <span><span class="ref-journal">J Am Geriatr Soc. </span>2008;<span class="ref-vol">56</span>:1770–1771.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19166457" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3712979&amp;issue-id=225165&amp;journal-id=928&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3712979/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3712979/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3712979/pdf/nihms3020.pdf">PDF (1.5M)</a></li> | <li><a href="#" data-citationid="PMC3712979" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3712979%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3712979%2F&amp;text=Vitamin%20C%20restores%20healthy%20aging%20in%20a%20mouse%20model%20for%20Werner%20syndrome"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3712979%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="19741171" data-aiid="3712979" data-aid="3712979" data-iid="225165" data-domainid="928" data-domain="capmc" data-accid="PMC3712979" data-md5="7f1d2517b7568ae12dc2eb63548c914e"></div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2018-07-16T20:35:53-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A2623B4D3966100000000004B004A&amp;ncbi_session=8A1A2623B4D39E81_0075SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3712979%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=capmc&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3712979/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- 8A1A2623B4D39E81_0075SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r563004 Tue, May 01 2018 03:01:28 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>
</html>